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ABSTRACT 
16 New Zealand White (NZW) rabbits were ovariectornised (OVX) and 20 left intact 
as age-matched controls. 4 controls were killed at time 0, then 4 from each group at 
1,3,6 and 12 months post-OVX. Serum oestradiol and body weight were recorded. 
Post-mortem of the OVX animals confirmed that all ovarian tissue had been removed. 
Femoral and humeral diaphyses were tested in 4-point bending, metatarsals in torsion 
and cancellous bone from the femora and humeri in compression. Oestradiol levels 
were not altered by OVX and there were no significant reductions in strength, 
stiffness or density of cancellous or cortical bone 12 months post-OVX, except that 
OVX femoral strength was significantly lower than control strength (p < 0.05). In 
conclusion, the species was not a suitable model for post-menopausal osteoporosis. 
Due to the failure of the rabbit model, it was necessary to revert to the rat model of 
post-menopausal osteoporosis. Two mechanical tests were used to investigate the 
efficacy of an anti-resorptive therapy (Oestradiol-3-benzoate) and an anabolic therapy 
(Parathyroid Hormone). An indentation test examined the properties of cancellous 
bone material, while the femoral neck bending test examined the properties of the 
bone as an organ by reproducing the in vivo events leading to a shear fracture of the 
hip. Biornechanical variables were related to Bone Mineral Density, a measure of 
bone mass currently in use in clinical practice, by scanning the bones using peripheral 
quantitative computed tomography (pQCT) before mechanical testing took place. It 
was found that cancellous bone density and indentation strength decreased and 
cortical bone density increased 6 weeks post-OVX: high levels of oestradiol-3- 
benzoate prevented these changes . Total bone mineral density was strongly correlated 
with indentation strength (r=0.92). Parathyroid hormone did not restore cancellous 
bone density of OVX to sham levels but restored biornechanical strength. z: 1 
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CHAPTER ONE 
Introduction 
Osteoporosis is the commonest human metabolic bone disorder, in which the quantity 
of bone is reduced, leading to an increased tendency to fractures, especially of the 
radius, femoral neck and vertebrae ("crush" fractures). The estimated annual cost of 
care of osteoporotic patients in the UK is at least E500 million (SCRIP, 1991) and the 
impact of post-menopausal osteoporosis is expected to reach epidemic proportions 
during the early part of the next century as the population ages (Lindsay, 1990). 
Post-menopausal osteoporosis is a primary osteoporosis, that is, a predisposing 
condition to which it is secondary cannot be found. The bone loss results from an 
imbalance between resorption and formation. Current treatments act only to inhibit 
the resorption of bone and not to stimulate its formation, so while they are valuable 
for preventing the disease from progressing further they still leave the patient with a 
bone mass which is below normal and therefore prone to fracture. 
The efficacy of new treatments must be assessed in animal models before they can be 
assessed in humans. The rat has been shown to lose bone rapidly after ovariectomy, 
reaching an osteopaenic state within a few weeks. Although fractures are uncommon tl 
in this species, the rat has been used to characterise histological and mechanical 
properties of osteopaenic bone and the effects of drugs on the osteopaenic state (Kalu, 
1991). 
The efficacy of treatments has, until recently, been assessed in animal models by non- 
invasive measures of bone mass or density such as Dual Energy X-ray Attenuation 
(DEXA) and photon absorptiometry. However, while density is a useful measure of 
the amount of bone present within a given volume, it is not necessarily a measure of Z: ý 
blornechanical competence. The strength of bone depends not only on its density but Z: ) 
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on its structure (Mosekilde et al., 1987 ) and the only way to determine the 
biornechanical competence of bone is by mechanical testing. However, from an Z: 1 
engineering point of view, specimens obtainable from rat cortical and cancellous bone 
are too small to give reliable results from mechanical testing. Instead, whole bones 
are frequently tested and the results of these tests may not be representative of the 
bone material. Whole bone testing has the added complication of size and shape 
differences between the bones and it is difficult to reproduce the in vivo loading. 
An ideal animal model would be one that responded quickly to loss of ovarian 
hormones yet gave bones which were large enough to permit the machining of 
standard engineering specimens. The New Zealand White rabbit was considered to be 
a suitable species, being small enough to have a fast metabolism and potentially rapid 
bone loss yet large enough to yield standard engineering specimens. The effects of 
ovariectomy on rabbit bone have not been widely reported; however, it has been 
shown that ovariectomy or high doses of prednisolone cause a decrease in bone 
mineral content assessed by dual photon absorptiometry of the spine and tibia (Sutter 
et al., 1991). 
One aim of this study was to investigate the effect of ovariectomy on the 
biomechanical properties of whole and standard specimens of bone and to determine 
whether the rabbit could be used as an animal model of osteoporosis. 
In the event of failure of the rabbit model it would be necessary to revert to the rat 
model of post-menopausal osteoporosis to investigate the efficacy of an antiresorptive 
therapy (Oestradiol-3-benzoate) and an anabolic therapy (Parathyroid Hormone). 
II 
CHAPTER TWO 
Literature Survey 
2.1 Development and Physiology of Bone 
Bone is a living, dynamic material. As a tissue it has two important functions, to act as a 
reservoir of calcium and other inorganic ions for the cells, tissues and fluids of the body, 
and to serve as a structural support allowing movement, locomotion and protection of vital 
organs. The reservoir function is dominant and has the power to overcome the structural 
function when this becomes necessary (Recker, 1992). 
2.1: 1 Bone Cells 
Bone, the skeletal support system of the body, is a dynamic tissue that is continually being 
formed by osteoblasts, maintained by osteocytes and removed by osteoclasts (Cross and 
Mercer, 1993). Osteoblasts originate from sheetlike mesenchymal cells lining the periosteal 
and endosteal bone surfaces and form monolayers adjacent to the surface of maturing or 
remodelling bone. In a young animal an osteoblast may remain on a surface for about 3 
days, during which time it will lay down 3 times its own volume of matrix (Vaughan, 
1975). They communicate with one another via gap junctions (Wheater , 1993). The 
major activity of osteoblasts is the synthesis and secretion of the organic matrix or 
'osteoid', which consists of collagen and other large molecules such as osteocalcin, 
osteonectin and proteoglycans. When active, the osteoblast is columnar or cuboidal in 
shape and 15 - 3014m across. Their cytoplasm contains many organelles which synthesise 
and secrete proteins. They are highly polarised cells (Gray, 1992) with the nucleus at the 
end furthest from the bone surface. Apposed to the matrix surface are many fine 
protoplasmic processes which penetrate the adjacent osteoid and mineralised matrix via fine 
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channels known as canaliculi. These cytoplasmic processes make contact with the plasma 
membranes of deeper osteocytes or osteocyte processes via gap junctions. In this way the 
action of quite large groups of osteoblasts may be co-ordinated, for instance in the 
formation of large areas of parallel collagen fibres (Gray, 1992). Osteoblast surfaces are 
rich in alkaline phosphatase activity, which leads to mineralisation of the osteoid matrix, 
and some alkaline phosphatase is shed, reaching the circulation, where it can be detected in 
conditions of rapid bone turnover. 
Osteocytes may be referred to as 'imprisoned osteoblasts' since they are osteoblasts which 
are surrounded by matrix, hence no longer functional as osteoblasts. It is thought that the 
osteocyte is "buried" in the bone matrix after it reduces its apposition rate relative to 
adjacent osteoblasts (Palumbo et al., 1990a). Differentiating osteocytes are in close contact 
with neighbouring osteoblasts and osteocytes throughout the whole differentiative process 
via intercellular contacts and gap and adherens junctions (Palumbo et al., 1990b). The 
osteocyte body lies in a cavity known as an osteocyte lacuna from which up to 100 
canaliculi extend containing cytoplasmic processes. The canaliculi may sometimes allow 
communication with neighbouring Haversian systems (i. e. across a cement line). The 
osteocytes contact each other and surface osteoblasts by many cytoplasmic processes to 
form a complex cellular network throughout bone. The average life span of an osteocyte is 
25 years (Gray, 1992). Although relatively inactive, osteocytes may be responsible for a 
small amount of matrix turnover since the sizes of their lacunae can change, and labelling of 
the growing bone indicates continuing matrix deposition (Gray, 1992). It is possible that 
by means of their communications with cells at the bone surface they may act as local 
sensors of mechanical and chemical states of bone and initiate erosion or addition of matrix 
accordingly. Old osteocytes may retract their processes from the canaliculi and, when 
dead, the canaliculi and lacunae become plugged with cell debris and minerals, hindering 
diffusion through the bone. Consequently, death of the osteocyte usually leads to 
resorption of the bone matrix and remodelling. 
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The osteoclast is a giant (around 100ýtm), fully differentiated, multinucleated cell, which 
originates from the fusion of several monocytes. They are found on bone surfaces which 
are undergoing resorption and have a ruffled membrane or brush border adjacent to the 
bone surface which comprises a series of fine finger-like cytoplasmic processes fanning out 
from the cell to terminate on the bone surface. Many lysosomes are concentrated at the 
bases of the clefts between these processes. Around the perimeter of the brush border is a 
sealing zone containing actin filaments - here the osteoclast is closely attached to the bone 
surface, so forming a limit to the brush border's resorptive activities. Osteoclasts lie in 
close contact with the bone surface in pits known as resorption pits or Howship's lacunae. 
Dernineralisation of the matrix occurs locally where the ruffled membrane of the osteoclast 
approaches the bone surface. A proton pump in the ruffled border maintains a high 
concentration of hydrogen ions in the resorption pit. The resulting low pH dissolves 
hydroxyapatite and activates lysosomal enzymes which dissolve the organic components of 
the matrix (Baron, 1989). 
Bone formation and resorption are closely coupled and one does not normally occur 
without the other. Osteoblasts may be essential for both processes, since in culture, 
osteoclasts will not resorb bone in the absence of osteoblasts, and receptors for parathyroid 
hormone, which increases bone resorption and osteoclast activity in vivo, are found on 
osteoblasts but not osteoclasts (Wheater , 1993). 
Osteoclasts and osteoblasts work 
together to balance resorption and formation during growth and the continual remodelling 
of bone, but from 20 years of age onwards the balance tends to shift so that resorption by 
osteoclasts is not completely repaired by osteoblasts (Wheater , 1993). The resulting 
decrease in bone mass may lead to an increase in fracture susceptibility. 
-14- 
2.1: 2 Bone Remodelling 
Bone is continually being remodelled, for example during growth when simple elongation 
of a long bone would not conserve its shape. Extra bone must be formed at the epiphyses 
and below the periosteum of the diaphysis to maintain its circumference to height ratio, 
while bone is resorbed from the endosteal surface to enlarge the medullary cavity of the 
bone so that the cortical bone of the diaphysis retains an optimal thickness with respect to 
strength and weight considerations. Another example can be seen in the growth of the flat 
bones of the vault of the skull - as the brain expands, the skull cavity must also expand 
while retaining its function as a protective casing, so bone is resorbed from the endosteal 
surface of the inner cortical plate and more bone is formed beneath the periosteum of the 
cortical bone of the outer plate - in this way the bone retains or even increases its thickness 
while decreasing its curvature and increasing its distance from the base of the skull. 
Remodelling does not stop in adult life and in the normal condition there is a balance 
between resorption and fon-nation of bone and the action of osteoclasts and osteoblasts are 
closely coupled. Hassler et al. (1980) defined 'remodelling' as a renewal process of bone, 
separate from its initial formation. It is said that the entire skeleton is renewed every 15 
years (Revell, 1986). One reason for this constant remodelling is the role of bone as a 
reservoir of calcium and other inorganic ions for the body. It is very important for the 
concentrations of these ions within the intra- and extracellular body fluid compartments to 
be maintained at a constant level (the mechanism by which this is achieved is called 
'homeostasis'). Various external factors such as low dietary intake may upset this balance, 
but the action of osteoclasts and osteoblasts, mediated by hormones whose synthesis and 
secretion are regulated by the levels of these ions in the blood or other body fluids, means 
that the skeleton is able to act as a buffer, taking up more calcium ions when the blood 
concentration is too high and releasing them when it is too low. This kind of remodelling 
can be seen in the replacement of primary osteons, present in cortical bone at birth, by 
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secondary osteons. A section through human cortical bone will show many secondary 
osteons, bounded by cement lines with 'interstitial bone' in between them - this interstitial 
bone is the remains of previous generations of osteons. Old secondary osteons are 
replaced by new secondary osteons. A space exists between the plasma membrane of the 
osteocyte and the bone matrix in both the lacunae and the canaliculi, known as the 
periosteocytic space, which is filled with bone extra-cellular fluid (ECF). A constant flow 
of calcium ions out of the bone is suggested by the fact that calcium concentration in the 
bone ECF is lower (0.5 mmol 1-1) than in the plasma (1.5 mmol 1-1). Although each 
periosteocytic space and the volume of bone ECF it contains are very small, the total 
surface area of the canaliculi and lacunae is between 1000 and 5000 M2 in adult humans, 
the volume of the bone ECF is 1-1.5 1 and the surface calcium contained in bone mineral 
crystals is 5- 20 g (Baron, 1989) and so it is thought that this is the pathway by which a ZD 
significant percentage of bone calcium is exchanged. 
The balance between resorption and formation is upset in certain disease states, for example 
in osteoporosis resorption exceeds formation and there is a net loss of bone. In Paget's 
disease the reverse may also occur and in certain bones, notably the bones of the skull, 
formation exceeds resorption and there is a net gain of bone material. 
As well as maintaining the shapes of bones, remodelling is also necessary to change the 
shape or the internal architecture of bones in response to strains put upon the tissue by 
gravity and muscle forces which may not act or may have a different action before birth 
when the primary bone is laid down. A tubercle that develops in response to a muscular 
pull is known as a traction epiphysis and has its own ossification centre. Examples can be 
seen where the patellar tendon inserts into the tibia, the biceps brachii tendon into the radius 
and in the greater and lesser trochanters of the femur where the abductors, adductors and 
internal and external rotators of the hip insert into the bone. The remodelling of bone in 
response to external forces is summarised in "Wolff s Law": 
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Every change in the form andjunction of bones, or in theirfunction alone, is followed by 
certain definite changes in their internal architecture and equally definite secondary 
alteration in their ewreme configuration, in accordance with mathernatical laws. (Wolff, 
1892) 
Workers including Field and Kenyon (1989) have attempted to define the exact nature of 
these laws but their model uses many assumptions about the shapes of bones and may 
contain large errors. 
The cancellous bone of the proximal femur is composed of two distinct systems of 
trabeculae forming two arches: one arising from the medial cortex and one from the lateral 
cortex (Singh et al., 1970). These are called compressive and tensile trabeculae, 
respectively, because they are disposed along the lines of maximum compressive and 
tensile stresses produced in the bone during weight bearing. It is well known that an arch 
is the simplest non-solid structure for withstanding compressive forces and as the femur is 
not solid due to the presence of the medullary cavity the trabecular arch transfers the 
compressive forces directly to the thick cortical bone of the diaphysis. The trabeculae of 
the proximal femuf-can be divided into five groups (Figure 2.1.1). 
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Figure 2.1.1 Arrangement of trabeculae in the proximal femur (from Singh et al., 1970) 
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Singh et al. (1970) examined radiographs of hips, grading them from six (normal) down to 
one (severe osteoporosis). It was seen that the principal compressive group of trabeculae 
were the last to disappear, as these were mechanically the most essential group of 
trabeculae. However, the Singh index was later found to have a very low, although 
significant, correlation (r = 0.49, p<0.01) with the breaking strength of the femoral neck 
in vitro (Leichter et al., 1982) and its clinical value is doubtful. 
Hert (1994) has a different theory about the fuctional adaptation of cancellous bone, in 
which the secondary cancellous bone develops from the primary cancellous lattice. The 
primary trabeculae are remodelled in the direction of maximum principal strain according to 
the strain-dependent mechanism of the functional adaptation of bone. Under successive 
loading from different directions the maximum principal strain attains the greatest value and 
morphogenetic importance in oblique trabeculae under load from two directions, 
corresponding to the two marginal positions of thejoint. The typical structure of two 
crossed trabecular systems, both pressure systems, develops. A tensile system can only 
develop in regions of direct tendon insertion or parallel to a concave joint surface. 
The three dimensional infrastructure of cancellous bone is strongly related to the strains 
placed upon it (Gibson, 1985). It is stated that cancellous bone constantly subjected to 
high loads would need to be of a high density to prevent cellular failure. In these situations 
bone takes on a closed cell, plate like structure. However, if the main function of the 
cancellous bone is to be of low weight e. g. within vertebrae, a low density open cell, rod 
like structure is formed. Similarly, if there is a multidirectional loading system an 
asymmetrical cell structure is formed but if the load is uniaxial a columnar structure is 
formed. 
The principal compressive strains on the cortical bone of pigs in normal walking were 
recorded by Goodship et al. (1979). It was found that after unilateral removal of the u1nar 
diaphysis the principal compressive strain on the radial shaft increased by 2-2.5 times its 
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normal value, causing a rapid and substantial remodelling response in the radius. Three 
months after removal of the ulna the cross-sectional area of the radius was approximately 
the same as that of the radius and ulna together in the contralateral limb. However, the rate 
of remodelling has been seen to decrease when unusually high loads have been placed on 
bones in vivo, as in the work of Hassler et al. (1980) on rabbit calvaria. The calvaria were 
placed under load and it was found, using a finite element model, that the formation rate of 
lamellar bone remained above control levels until stresses of approximately 2.48 MPa were 
reached. Above this level the remodelling rate fell to, or below, that of the control. 
Fibrous bone exhibited higher formation rates which decreased with increasing stress but 
remained above control levels. The authors concluded that there may be a stress-induced 
inhibition of the remodelling process. Some of their previous work (Hassler et al., 1974) 
on osteotornised rabbit calvaria had established a correlation between applied compressive 
stress and calcium formation, collagen synthesis and histologic interpretation. 
The mechanisms involved in translating mechanical situations within the matrix of bone 
into a stimulus recognisable by the cells are as yet unknown, but Lanyon (1984) showed 
that experimental alterations in bones' strain environments are a powerful determinant of 
their remodelling behaviour. A proportional relationship was established between the peak 
strain magnitude of an intermittent strain regime and the osteogenic response it 
engendered. The observations of Chamay and Tschantz (1972) on dog u1nae also indicated 
that the mechanical stimulus must be inten-nittent rather than static in order for remodelling 
to take place. 
2.1: 3 Hormonal Factors 
Calcium homeostasis is the most important physiological function of the skeleton. A stable 
concentration of calcium ions is essential for maintaining normal permeability of cellular 
membranes and excitability of nerves and muscle, the release of neurotransmitters, many 
hormones and exocrine secretions, muscular contraction, coagulation of blood, production of Cý 
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milk and for the activity of many enzymes. More than 98% of the body's calcium is found in 
bone. The plasma calcium concentration Is about 2.5 mmol 1-1 of which about 1.5 mmol 1-1 
is ionised, the remainder being bound to plasma proteins and to anions such as citrate. The Z: ) 
calcium concentration in interstitial fluid is 1.5 mmol 1-1. Phosphorus metabolism is 
regulated in a similar manner to that of calcium and about 80% of the 16 mol of the body's 
phosphorus is contained in bone. Only 1% of the ionised calcium and phosphate in bone is 
in equilibrium with the extracellular fluid - this fon-ns the 'exchangeable pool' which acts to 
buffer small short term changes in blood concentrations of calcium and phosphate. The 
remaining 99% of bone is not in equilibrium with the extracellular fluid and is referred to as 
'non-exchangeable' bone. This 'non-exchangeable' bone is constantly being broken down 
and remodelled by the action of the bone cells which are regulated by parathyroid hormone 
and calcitonin as well as by several other hormones, especially during growth (Bray et al., 
1986). 
Calcium metabolism is controlled, mainly, via three hormones - parathyroid hormone, 
cal4tonin and 1,25-dihycjpxycholecalciferol, the active metabolite of vitamin D3 (calcitriol). 
2.1.3 (i) Parathyroid Hormone 
Parathyroid hormone (PTH) is the most important hon-none involved in calcium 
homeostasis (Wright, 1983). It is an 84 amino acid polypeptide which is secreted by the 
four parathyroid glands located in the dorsal surface of the lobes of the thyroid gland in the 
neck. Its secretion is regulated solely by the level of plasma calcium acting on the Zý 
parathyroid glands and varies inversely with plasma calcium levels. A drop in plasma 
calcium is sensed by calcium receptors which send signals to stimulate the release and zn 
synthesis of PTH. Its action on the skeleton, kidneys and, indirectly, on the 
gastrointestinal tract leads to an increase in ionised calcium in the plasma and a 
corresponding decrease in plasma phosphate. A negative feedback mechanism is in Zý 
operation since the release of PTH leads to an increase in extracellular calcium and so 
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further release of PTH is inhibited. The action of parathyroid hormone on the skeleton and 
the kidneys appears to be energy dependent (Bray et al., 1986). It acts to increase the rate 
of bone resorption by stimulating the activity and formation of osteocytes and osteoclasts; 
this effect is important in the long term regulation of plasma calcium but its effects on the 
kidney and indirectly on the uptake of calcium in the gut are more important in 
compensating for short term changes. PTH acts on the kidney to retain calcium and 
stimulates 25 - synthase to increase the rate of conversion of 25-hydroxycholecalciferol to 
1,25-dihydroxycholecalciferol (Vitamin D3). This stimulates the gut to increase calcium 
uptake and causes the parathyroid cells to take up more calcium which they then interpret as 
an increased plasma calcium concentration. This lowers the set point at which plasma 
calcium concentration increases PTH secretion. These changes in the rate of PTH secretion 
and increased calcium uptake and retention last for 20 minutes before the hormone is 
broken down by the liver. 
The osteolytic effect of PTH has two phases: 
a. Early phase A few minutes after PTH is released plasma calcium concentration 
increases, due to increased flow of calcium ions from deep bone to the surface. This is 
probably caused by the extrusion of bone fluid from the osteocytic lacunae. The early 
phase has a smaller and less important effect than the late phase of PTH action. 
b. Late phase This occurs hours or days after the release of PTH. Osteoprogenitor 
cells multiply and become osteoclasts. Increased resorption of bone mineral by these 
osteoclasts is accompanied by increased release of lysosomal enzymes leading to increased 
destruction of collagen and the other organic proteins. During this process calcium and 
phosphate are liberated into the extracellular fluid. 
PTH has the secondary effect of increasing osteoblast fon-nation and promoting collagen 
biosynthesis and new bone fon-nation. Normally the increased resorption and increased 
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formation of bone are balanced to bring about remodelling of bone without a net gain or 
loss in bone mateiial. 
2.1.3 (ii) 1,25-Dihydroxycholecalciferol (Vitamin D, 21 
Vitamin D3 is a steroid prohormone. It is found in the diet and is also formed by the action 
of ultra-violet light in the skin. In the liver a hydroxyl group is added to cholecalciferol at 
the carbon-25 position and in the kidney another hydroxyl group is added to the carbon-1 
position. This occurs increasingly as extracellular concentrations of calcium or phosphate 
decrease and is stimulated by PTH. The hormone acts on the small intestine to promote the 
absorption of calcium and phosphate ions and, with PTH, causes the release of these ions 
from the skeleton. 
Vitamin D3 has also been shown to stimulate differentiation of many cell types, including 
osteoblasts, and to stimulate several osteoblast activities including alkaline phophatase 
activity and production of type 1 collagen and osteocalcin (Franceschi et al, 1988). Vitamin 
D3-specific receptors have been found in osteoblasts (DeLuca, 1988) and a response 
element has been found in the promoter of the osteocalcin gene (Yoon et al., 1988). 
Osteocalcin is a protein produced only by osteoblasts and preosteoblasts. This evidence 
suggests that the effects of vitamin D3 as an osteoblast differentiation agent are mediated by 
direct action on osteoblasts. 
2.1.3 (iii) Calcitonin 
Calcitonin is a polypeptide which is secreted by the parafollicular'C' cells of the thyroid 
gland. The action of calcitonin leads to a decrease In plasma calcium concentration by 
inhibiting the action of osteoclasts and possibly osteocytes, thus decreasing the rate of 
resorption, and by inhibiting the re-uptake of calcium in the kidney. Release of calcitonin 
is stimulated by a raised plasma calcium concentration. In man, the plasma calcitonin 
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concentration increases in direct proportion to increases in plasma calcium concentration 
above 2.3 mmol 1-1 (Bray et al., 1986). 
Dietary intake 
25 mmol/day 
10 
Vit D 
/5 
'o increa s // 
EXTRACELLULAR 
FLUID 
Total 25 mmol 
Filtered 
200 mmol/day 
PTH increases 
GUT 
Faeces 
20 mmol / day 
9 
Reabsorbed 
195 mmol / day 
PTH increases 
KIDNEY 
Urine 
5 mmol / day 
Calcitonin 
-ncreases Incre 
a anld rd 
I 
NK N", incmase ý9 
BONE 
Total 25000 mmol 
Figure 2.1.2 Flow diagram showing the interactIons of calcium regulating hormones 
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2.2 Structure of Bone 
Bone is a biphasic composite material made up of an organic matrix of collagen fibrils 
embedded in an amorphous substance with mineral cystals precipitated within the matrix 
(Recker, 1992). In mature bone, between 10 and 20 % of the matrix mass is water and, of 
its dry weight, 60 - 70 % is made up of inorganic mineral salts (hydroxyapatite-like crystals 
and amorphous calcium phosphate), 30 - 40 % is collagen. The remainder is protein and 
carbohydrates, mainly conjugated as glycoproteins such as osteocalcin and osteonectin 
(Gray, 1992). 
2.2.1 Collagen - Structure and Properties 
Collagen fibres are made up of narrow (20-200nm diameter) collagen fibrils, themselves 
comprised of fine (3.5nm diameter) ir: iicrofibrils, which are aggregates of filamentous 
tropocollagen molecules. Each tropocollagen molecule is around 300nm long and 1.4nm 
across and is composed of three (x (or procollagen) polypeptide chains. Every third amino 
acid in the chain is glycine, this is important to allow the chains to approach one another so 
that hydrogen bonding can take place between them. In collagen 1, each tropocollagen tl 
molecule has one U-2 and two (xj chains which associate into a triple helix with covalent 
bonds between the chains via proline residues. Once the tropocollagen molecules have 
been secreted they associate into collagen microfibrils; hydroxylysine residues with 
carbohydrate attachment sites appear to be essential to this process (Gray, 1992). Within 
each microfibril the tropocollagen molecules are arranged in five rows with a gap of 40nm 
between the end of each and the next. Each unit spans four 67nm intervals, overlapping 
the fifth by 27nm, and each row has a 67nm quarter stagger to its lateral neighbour giving 
collagen a 'banded' appearance. Synthesis begins in the ribosomes of osteoblasts and Z! ý 
procollagen is secreted into the extracellular space. 
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Figure 2.2.1 Collagen Fibrils twisted into a Triple Helix (from Gross, 1961) 
To date, 13 different types of collagen with different sequences of amino acids have been 
described. The main type found in bone is type 1, however trace amounts of types III, V 
and XI have been isolated from the mineralised matrix (Niyibizi and Eyre, 1989) and 
immunohistochernical and in situ hybridisation studies have localised small amounts of 
type XII (Sugue et al., 1989) and type X111 (Pihlajaniemi et al., 1990) to developing bone. Zý 
The only information available on the mechanical properties of collagen is from vertebrate 
tendon and ligament, which is mainly composed of Type I collagen (70-80% dry weight). 
Katz (1980) states that collagen is a viscoelastic material with good energy absorbing Z: I 
characteri sties. Collagen has a high modulus of elasticity, for a biological material, of I-2 ýn 
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GPa and a high tensile strength of 50 - 1000 MPa (Bennet et al., 1986). Collagen fibres in 
vivo are 'crimped' and, on the application of a tensile force, straighten out and become 
parallel. This corresponds to the 'toe-in'region on the collagen stress-strain curve. In 
tendons, the length of the 'toe-in' region varies with the source of the tendon and so the 
amount of crimping is assumed to vary in different collagens. After the toe-in region, 
elastic behaviour is seen up to a strain of approximately 0.04 (Figure 2.2.2). Collagen 
fractures at a strain of 0.08 - 0.1 (Katz, 1980) due to the disruption of interactions between 
adjacent collagen fibrils. According to Gray's Anatomy (1992) "it is clear that besides 
contributing to the tensile, compressive and shearing strengths of bone, the small degree of 
elasticity shown by collagen imparts a measure of resilience to this tissue, helping to resist 
fracture when mechanically overloaded". Dry collagen is brittle and stiff with a Young's 
modulus of around 6 GPa (Vincent, 1990). Water is added first to the integral structure of 
the alpha chains and next comes to be associated with the charged side of the chain. 
Collagen fibres are also vital to bone development by providing nucleation sites within their 
substructure for mineral deposition. 
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2.2.2 Bone Mineral 
The mineral component of bone is largely composed of calcium phosphate, mainly in the 
form of hydroxyapatite (CaiO(PO4)6OH2). This forms needle shaped crystals, 20 - 40 nm 
long and about 1.5 -3 nm wide. Bone mineral is not pure hydroxyapatite but also 
comprises calcium carbonate, with lesser quantities of sodium, magnesium and fluoride, 
and all these components are present as a mixture of hydroxyapatite crystals, carbonate 
apatite and amorphous calcium phosphate (Vaughan, 1975). The long axis of the crystal 
plate is aligned with the collagen fibrils (Bacon et al., 1977). The Young's modulus of 
hydroxyapatite is around 85 GPa (Best, 1990), and its ultimate tensile strength is 100 Mpa. 
It has a low capacity for energy absorption and a low fracture toughness (<1 MNm-3/2), 
that is, once a crack is initiated it will propagate easily. 
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Figure 2.2.3 The relationship of apatite crystals to collagen fibrils (from Bacon et al., 
1977) 
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Precipitation of mineral within osteoid may proceed with the formation of a precursor 
amorphous calcium phosphate which may then be rapidly converted to octacalcium 
phosphate. In the initial stages of cartilage and woven bone mineralisation, matrix vesicles, 
which are rich in alkaline phosphatase, seem to be important and there is homogeneous 
hydroxyapatite nucleation within the lumen of the vesicle. In more mature bone, 
mineralisation occurs mainly by heterogeneous nucleation within the'holes' between the 
tropocollagen molecules which occur every 67 nm within collagen fibrils. These holes 
measure 40 nm and are the site of precipitation of approximately half the mineral in the 
mature bone. The other 50% is precipitated along the length of the fibres and between 
them, with non collagenous fibres also occupying this space (Recker, 1992). Some of the 
hydroxyapatite crystals coalesce during growth to forrn polycrystalline layers which 
ensheathe the collagen (Bonfield and Li, 1967). The role of collagen in mineralisation is 
not clear, since heterogeneous nucleation requires that the nucleator has a high affinity for 
the nucleating ions and the molecular topography of the nucleator must be complimentary to 
the surface of the precipitating mineral. Since collagen does not have these properties it is 
possible that the collagen fibre may act as a scaffold upon which the real nucleators e. g. 
osteocalcin, osteonectin, thrombospondin and osteopontin are bound (Gehron Robey et al., 
1992). 
2.2.3 Compounds associated with Bone Mineral 
Ground substance consists mainly of proteoglycans, which are proteins attached to 
glycosaminoglycans. The ground substance holds many negatively charged ions e. g. 
COOH- and S042- groups which attract Na+ ions. This creates a large osmotic pressure in 
the tissues so water is drawn into the ground substance and may exert a hydrostatic 
pressure, although this is not as important in bone as it is in softer connective tissues such 
as cartilage where it goes some way towards withstanding the compressive stresses 
imposed on the body. 
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Grynpas et al. (1988), investigating the relation between bone mineral and 
glycosaminoglycans, found that hydroxyapatite crystal size increased substantially from 
new-born to mature rabbits whilst GAG content decreased and concluded that calcification 
and maturation of bone is associated with a decrease in the proteoglycan content of the 
organic matrix. 
Osteonectin acts as an adhesive between collagen fibres, bone crystals and the cells of 
bone. Osteocalcin is thought to play a role in calcium deposition. The phospholipids, 
glycosan-iinoglycans, phosphoproteins and other organic substances present in small 
amounts in the matrix may be important in early rriineralisation and in the maintenance of 
calcium salts within mature bone (Gray, 1992). Osteocalcin production is stimulated by 
vitamin D3 (Franceschi et al., 1988) and together with osteopontin and osteonectin may act 27, 
as nucleators which aid the deposition of bone mineral between the collagen fibres. 
2.2.4 Microscopic Organisation of Bone 
Bone is comprised of a highly organised structure of mineral and organic components. z: I 
The simplest structure is woven bone - this is the type predominant in foetal bones and in 
callus formation after a fracture. Fine fibred collagen, about 1 ýtm in diameter, is oriented 
almost randomly (Currey, 1984). The orientation of the collagen bears no relation to that 
of the mineral crystals. Often there are large spaces surrounding the blood vessels and as 
in mature bone the osteocytes communicate with each other and with the blood vessels via 
narrow channels or canaliculi. 
Woven bone is normally replaced by lamellar bone which is laid down more slowly, is 
more precisely arranged and less highly mineralised. The mineralised bone matrix is 
arranged in sheets or lamellae which are approximately 5 ýLrn thick (Currey, 1984). The z: I 
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collagen in any particular lamella is oriented in the plane of the lamella and all the fibres 
tend to be oriented in one direction within the plane of the lamella. A sheet of 'interlamellar 
bone' about 0.1 ýtrn thick fonns a division between one larnella and the next. 
This traditional collagen - dominant model of bone structure has recently been challenged 
by Hasegawa et al. (1994) who used acoustic microscopy on cortical bone specimens from 
dog femurs before and after removal of the mineral or the collagen phase. The authors 
claimed that the traditional model was based on studies of the mineralising turkey tendon 
alone and that the mineralisation of bone may be substantially different. They argued that if 
the traditional model was correct, both inorganic and organic phases of bone should have 
similar elastic anisotropy. They found that the anisotropy ratio decreased significantly after 
dernineralisation but there was no similar change after the removal of the collagen phase. It 
was concluded that the orientation of the mineral crystals is the primary determinant of bone 
anisotropy and that the collagen matrix within osteonal bone has little directional 
orientation. 
Within either of these ultrastructural models, the larnellae are layered up to give either 
circumferential, or Haversian bone, which is also known as osteonal bone. 
Circumferential bone is found in many mammals, for example cows, where the larnellar 
bone is wrapped around the outside, or periosteal surface, and/or the inside, or endosteal 
surface, of bones. There are blood channels within the circumferential bone but they do 
not disturb the general arrangement of the lamellae. Haversian bone consists of Haversian 
systems or osteons. Each osteon consists of a central Haversian canal, which contains one 
or two blood vessels, surrounded by concentric cylindrical lamellae. Secondary osteons 
are formed when the bone around a blood vessel is eroded away by the action of 
osteoclasts leaving a cavity up to 70ýtm in diameter. The walls of the cavity are made 
smooth and bone is deposited on the internal surface by osteoblasts in the form of 
concentric lamellae. The first osteons to form in the developing animal are known as 
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primary osteons and are not separated from the rest of the bone by a cement line, nor do 
they replace pre-existing bone (Currey, 1982). Primary osteons are soon replaced, in 
humans and many other animals, by secondary osteons. Every secondary osteon is 
surrounded by an outer sheath, known as the cement line, which is made of highly calcified 
mucopolysaccharides with practically no collagen. It is rare for canaliculi to cross the 
cement line (Gray, 1992). 
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Figure 2.2.4 A section through mature cortical bone showing the arrangement of the 
circumferential, lamellar and Haversian bone (from Wheater et al., 1993) 
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Formation of osteons usually leads to the formation of more osteons because so few 
canaliculi pass across the cement line bounding each one that the blood vessels become 
separated from the interstitial bone material, leading to osteocyte death which in turn leads 
to remodelling (Currey, 1982). Z: ý 
Primary bone has been shown to be both stronger and stiffer than secondary bone (Evans, 
1973; Reilly and Burstein, 1975). This is probably because cement lines are the weakest 
part of bone, having a very low collagen content, and because fractures tend to follow 
them. In separate analyses of osteonal and non-osteonal specimens Martin and Ishida 
(1989) noted that the osteonal specimens were weaker, but they attributed this to a less 
longitudinal orientation of the collagen fibres, rather than to increased numbers of cement 
lines. 
The formation of secondary osteonal bone is an example of the dominance of the reservoir 
function of the skeleton over its mechanical function. Constant remodelling ensures that 
the bone mineral is always available to maintain mineral homeostasis, even though 
secondary bone is mechanically weaker than primary bone in tension. 
Evans (1973) observed that interstitial lamellae tend to increase the tensile strength and 
stiffness of bone. However this could be misleading; as remodelling progresses interstitial 
lamellae will be replaced by secondary osteons and so the negative effect seen with 
decreasing volume of interstitial lamellae is probably simply due to a higher volume of 
secondary osteons. 
Katz (1980) developed a hierarchical model for the composite nature of bone, based on the 
elements described previously, comprising three levels (figure 2.2.5): Zý Z: ) 
LEVEL 1. MOLECULAR. Katz uses the traditional collagen- based bone model, with Z: I 
the c-axis of hydroxyapatite crystals assumed to be aligned with the fibrils. The other 
organic components play an important role in stabilising the structural organisation. 
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LEVEL 2. ULTRA STRUCTURAL. A single osteon is immersed in a matrix which Z: ý 
consists of ground substance, collagen and mineral in the cement line, and adjacent 
interstitial lamellae. 
LEVEL 3. MICRO STRUCTURAL. The osteons are assumed to be packed in a near 
hexagonal arrangement (figure 2.2.5) as suggested by the results of microscopic 
observations and ultrasonic wave propagation measurements. 
24" 
Figure 2.2.5 Katz's model of the composite nature of bone (from Katz, 1980) 
Currey (1989) proposed an analogy for bone in which he compared it to fibreglass; a glass 
fibre-reinforced epoxy resin matrix. He suggested that the n-iineral phase of bone is similar 
to the glass fibres in fibreglass because it acts to reinforce the matrix material, as described z: l 
in the lowest level of Katz's (1980) model. Burstein et al. (197_,, ý, ) tested this hypothesis by 
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investigating the individual contributions of the collagen and mineral phases to bone 
strength in the elastic and plastic regions of the stress-strain curve. By sequentially 
demineralising machined strips of cortical bone and subjecting them to bending loads, the 
mineral phase was shown to contribute the major proportion of bone strength in the elastic 
region, whereas the plastic region of the stress-strain curve was shown to be solely a Z: ) 
function of the matrix. 
Carter and Hayes (1977) also suggested a composite model for bone as a biphasic porous 
material. In this, whole bones were modelled as composite structures consisting of a solid 
phase, which is the mineralised bone matrix and a fluid phase, which comprises blood 
vessels, blood, red and yellow marrow, nerve tissue, miscellaneous cells and interstitial 
fluid. The fluid phase was shown only to cause a definite increase in the overall 
mechanical properties at high strain rates, around 10 s-1- 
2.2.5 Macroscopic Organisation of Bone 
Bone is found in two macroscopic forms: cortical and cancellous. Cortical bone is also 
known as compact bone and is up to 97% solid, the only spaces within it being for 
osteocyte lacunae, canaliculi, capillaries and resorption pits. It is found in the diaphysis of 
a long bone, where it forms a hollow cylinder, or as a thin shell on the outside of short 
bones such as the carpal bones of the wrist where it surrounds cancellous bone. Cortical 
bone in adult humans is usually made of secondary osteonal bone (Figure 2.2.4. ) 
Cancellous bone contains large spaces which are visible with the naked eye. It is 
structurally similar to a foam (Gibson, 1985) and is found at the ends of long bones, as the 
spongy filling of short bones such as the carpals of the wrist, as a filling in the flattened 
bones such as the diploý of the skull and under protuberances into which tendons are 
attached. Cancellous bone acts to absorb shock and distribute load in the vicinity of the 
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articular surfaces of joints (Holmes et al., 1984). The material which makes it up is usually 
primary lamellar bone or fragments of Haversian bone. Zýl 
2.3 Mechanical Properties of Cortical Bone 
There is a wide variation in the measured mechanical properties of cortical bone (Gibson, 
1985). Values of Young's modulus range from 4 to 25 GPa, tensile strength from 80 to 
150 MPa, compressive strength from 90 to 280 MPa and flexural strength from 150 to 240 
MPa. 
2.3.1 Effects of Fibre and Collagen Orientation 
The direction of Haversian canals within the bone affects its mechanical properties. It is 
able to withstand more force in the longitudinal direction than in the transverse direction in 
both tension and compression (Recker, 1992). The collagen fibre or the Haversian canal or 
both are thought to take forces from the matrix through shear forces developed at the fibre- 
matrix interface. The transfer of force takes place along a length of fibre deten-nined by the Zý 
relative moduli of the matrix and the fibre, conditions at the interface and the diameter of the 
fibre. For the fibre to behave as an effective reinforcer it must be at least twice this transfer 
length (Vincent, 1990). 
Micro- and macro-hardness of bone were investigated by Amprino (1958) and, while 
limited correspondance was found between them, microhardness values were consistently 
and significantly 20 - 25% higher in sections in which collagen fibres were cut 
perpendicularly than in sections cut parallel to the long axis of the fibres. Bone samples cut 
in a plane parallel to the longitudinal axis of a long bone aligned with the Haversian canals C' Z: ý z: I 
have a modulus of elasticity approximately twice that of samples cut in a perpendicular 
plane. This is due to differing orientations of the osteons. Although the experimentally 
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determined value of the Young's modulus for all bone types is 4- 30 GPa, for longitudinal 
orientations the modulus of human bone in tension was found to be 17.9 ± 3.92 GPa, for 
radial orientations 10.5 ± 1.48 GPa and for tangential orientations 10.1 ± 2.35 GPa (Reilly 
and Burstein, 1975). Osteonal bovine bone was also found to differ significantly in its 
modulus of elasticity, depending on the orientation of the specimens with respect to the 
long axis of the bone, from 23.1 ± 3.18 GPa in the longitudinal orientation to 10.4 ± 1.64 
GPa in the radial and tangential orientations (Reilly and Burstein, 1975). Bonfield and 
Grynpas (1977) measured the Young's modulus of compact bone from the mature bovine 
femur at various angles from 0 to 90 * to the long axis of the bone, using an ultrasonic 
technique. They found that the modulus decreased from 0 to 20 *, 'plateau-ed' from 20 to 
70 ' and decreased again from 70 to 90 *. This result conflicted with those predicted for a 
fibre reinforced model for bone. 
The tensile strength of bovine compact bone when loaded parallel to the long axis of the 
bone was determined by Reilly et al. (1974) to be 146 ± 10.7M-Pa. Its compressive 
strength similarly was determined as 212 ± 6.2 MPa. Studies on the tensile strength of 
bovine cortical bone (Martin and Ishida, 1989) showed, with linear regression analysis, 
that the collagen fibre orientation was consistently the single best predictor of strength - the 
more longitudinally the fibres were oriented, the stronger the bone. The relationship of 
collagen fibre orientation and calcification to tensile and compressive properties of 
individual human and bovine osteons was studied by Ascenzi and Bonucci (1967 & 1968). 
The tensile strength and modulus of elasticity were higher in osteons whose collagen fibres 
had a markedly longitudinal arrangement than in those whose fibre bundles changed 
through a right angle in successive lamellae. Significant positive correlations between 
compressive strength of bone and percentage osteons, regardless of their collagen fibre 
orientation, were found by Evans and Vincentelli (1974) which suggests that osteons tend 
to increase the compressive strength of bone. This is interesting since Evans (1973) and 
Martin & Ishida (1989) both found that increasing numbers of osteons led to a decrease in 
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tensile bone strength. It was suggested by Shah et al. (1992), working with equine bone, z: 1 z: 1 
that the greatest remodelling occurs in areas subject to mainly compressive loading and that 
although remodelled bone is less stiff in tension it may be better adapted for compressive 
loading. 
Significant positive correlations between shear strength and osteons whose collagen. fibres 
are predominantly longitudinal were found by Evans and Vincentelli (1969). The authors Zý 
also found significant positive correlations between shear strength, Young's modulus and 
percentage elongation and osteons with a mixed arrangement of collagen fibres and 
significant negative correlations between shear strength and Young's modulus and osteons 
in which collagen fibres are at an acute angle to the long axis of the osteon. 
2.3.2 Viscoelastic Properties 
Bone demonstrates viscoelastic behaviour within the normal range of physiological loading Z: ý 
(which varies from 4- 12.5 MPa or 1500 - 2500 ýtstrain in the tibia (Carter, 1978)) and 
this provides an important mechanism for dissipating energy during deformation. A series 
of closed hysteresis loops were found when the non-elastic tensile deformation 
characteristics of compact bovine and rabbit bone were measured, which suggested that 
nonelastic strain was due entirely to anelastic deformation (Bonfield and O'Connor, 1978). 
Loading bovine compact bone in tension gave greater values for yield stress, ultimate 
tensile strength, Young's modulus and strain at yield at higher strain rates (Currey, 1975). 
When equine cortical bone was loaded in tension all the mechanical properties, with the 
exception of ultimate tensile strength, were strain rate dependent throughout the test range 
10-5 S-1 to I s-1 (Evans, 1989). When the microdeformation of bone filaments under 
torsional loading was studied (Bonfield and Li, 1967) a departure from elastic behaviour z: 1 
occured at a small applied stress level and appreciable amounts of nonelastic strain were 
produced at stress levels considerably below the fracture stress. It was suggested that the 
initial nonelastic flow occured in the collagen, thus decreasing its effective "modulus" and Z: ý 
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an increasing percentage of the applied load was then supported by the hydroxyapatite, C, ZD 
which continued to deform elastically. On unloading, the extended collagen fibres reached 
a condition of zero strain when the hydroxyapatite crystals were still elastically strained. If 
the bone was allowed to remain at zero stress, it was suggested that anelastic recovery 
would take place in the collagen, allowing some reduction in the elastic stress retained in 
the hydroxyapatite. The internal stress in the apatite may also have been relieved by the 
local convolution of the collagen fibres to take on a more irregular configuration. 
2.3.3 Hardness 
Hardness and Young's modulus, along with other mechanical properties of compact bone, 
were determined by Currey and Brear (1990) and hardness was found to be a very good 
predictor of of the Young's modulus and the yield stress, but a poor predictor of the 
ultimate stress. The relationship between the variables in each case was nearly linear. 
They suggested that hardness would be a useful guide to the mechanical properties of 
mineralised tissues in situations where conventional test specimens could not be produced 
or where variations in mechanical properties over small distances are of interest. 
Variations of bone microhardness with cross sectional position in the diaphyses of femurs 
and tibias from various species were investigated by Balderson (1994). A general pattern 
of a decrease in hardness from anterior to posterior sides and little or no variation between 
the average n-krohardness values of the medial and lateral sides was observed. 
2.3.4 Effect of Mineral Content 
A relationship between the degree of calcification and the hardness of bone was seen by 
Amprino (1958) only when other structural characteristics in the tested areas were equal. 
The energy absorbed by rabbit metatarsal bone in static and dynamic loading was observed 4: 1 
to increase and then decrease with ash content (Currey, 1969). The highest values were 
seen at the median value for ash content. Later Currey (1988) found that the modulus of 
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elasticity had an approximately cubic relationship with calcium content and volume fraction 
(which is inversely proportional to porosity). The conclusion was that bone was a three 
phase composite, the volume fraction of water decreasing as the mineral increased. 
Alterations in the chemical interactions between the collagen and the mineral were possible 
as the mineral volume fraction increased. A strong relationship was also observed between 
hardness and calcium content in compact bone (Hodgkinson et al., 1989). Since the 
variation in Young's modulus is produced mainly by variation in mineralisation, a 
relationship between hardness and Young's modulus of compact bone was effectively 
demonstrated. A significant increase in the stiffness of bone from older rabbits was 
demonstrated by Bonfield and Clark (1973), due to both increased mineral volume fraction 
and decreased porosity. However, n-dneralisation of the bone matrix was found to be a 
poor predictor of strength (Martin and Ishida, 1989). The porosity distribution in a given 
sample of bone was found to be much more significant in its effect on strength and 
Young's modulus in bone of low relative density than in bone of high relative density 
(McElhaney et al., 1970). 
When looking at compact bone from many animals, in tension, it was seen that the ultimate 
strain, ultimate stress and the work under the stress-strain curve declined sharply with 
mineralisation (Currey, 1990). 
2.3: 5 Factors which affect the measured mechanical properties of bone 
2.3.5 (i) DEying 
Drying leads to an increased Young's modulus and increased bending strength and makes 
bone more brittle (Currey, 1988). The tensile and compressive strength characteristics, the 
modulus of elasticity and the hardness of bone were all increased by drying. The shear 
strength perpendicular to the long axis of the bone and its energy absorbing capacity were 
both decreased by drying (Evans, 1973). However, drying and rewetting was shown by 
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Currey (1988) in bending tests on bovine bone to produce a 5% decrease in bending 
strength which, although statistically significant, is small in comparison with the range of 
variation seen between bones and it was concluded that the effect of drying and rewetting 
could be ignored, at least in compact bone. Investigations into buckling of single 
trabeculae (Townsend et al, 1975) gave the Young's modulus of wet trabeculae as 11.37 
GPa and the mode of buckling as ductile, whereas the Young's modulus of dry trabeculae 
was 14.12 GPa and the mode of buckling was brittle. Elastic and plastic flexural properties 
of mouse femora after dehydration times from 0.25 to 48 hours were deterrnined by Broz et 
al. (1993). They found that dehydration produced increased stiffness and strength and 
decreased ductility. A statistically significant linear dependence of mechanical properties on 
recovered free water was seen for all parameters except the maximum load. After three 
hours of rehydration there were no statistically significant differences with respect to the 
control (never dehydrated) values. 
2.3.5 (ii) Preservation Effects 
Alcohol fixation leads to significant and irreversible reductions in the deflection of human 
tibial bone in bending, and enbalming increases the mean ultimate tensile strength and 
strain, modulus of elasticity in tension and hardness of wet cortical bone from adult male 
tibiae (Evans, 1973). However, no statistically significant changes were observed in the 
bending properties of human cortical bone that had been frozen at -20*C for 3-4 weeks and 
subsequently thawed before testing. 
2.3.5 Gii) Temperature Effe ts 
The modulus of elasticity has an approximately linear but inverse relationship with 
temperatures within the normal body range (Evans, 1973). In an ultrasonic analysis by 
Bonfield and Tulley (1982) a linear decrease of approximately 0.07 GPa was demonstrated 
for each 'C rise in temperature. This effect was completely reversible with temperatures in 
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the 17 - 41'C range. Stress-strain behaviour of bone at room temperature is very similar 
for compression and tension except that the ultimate tensile strength is lower than ultimate 
compressive strength (Evans, 1973). 
2.3.5 Ov) Strain rate 
The rate of loading of a specimen is important because of the viscoelastic properties of 
bone; the faster the load is applied the less the bone will have relaxed. However, this is 
really only a problem at high strain rates. Trabecular bone specimens were found to be 
stronger in compression at low strain rates (Galante et al, 1970), and the fracture mode of 
osteonal mandibular bone was found to be a strong function of strain rate (Margel- Zý 
Robertson and Smith, 1978). 
2.4 Mechanical Properties of Cancellous Bone. 
2.4.1 Architecture of Cancellous Bone 
When considering the strength of cancellous bone, its structure must be taken into account, 
including lateral support of longitudinal columns due to transverse struts and bending 
moments around those parts of longitudinal struts which are not aligned with the ends of 
the struts. Mosekilde et al. (1987) found that the biomechanical competence of human 
vertebral trabecular bone in compression testing depended not only on ash density but also 
on the continuity of the trabecular lattice, which decreases with increasing age. 
According to Currey (1984) the structure and mechanical behaviour of cancellous bone is 
affected by three factors 
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i. Fine scale anisotropy According to Singh (1978) the simplest kind of cancellous 
bone in humans consists of randomly onented cylindrical struts about 0.1 mm in diameter, 
each extending for about I mm before making a connection with one or more struts. As the 
density increases, the struts are replaced by plates. Cancellous bone varies from that in 
which there is an occasional plate among the struts to cancellous bone in which there is an 
occasional strut among the plates. McElhaney et al. (1971) found that the structure of 
cancellous bone strongly influences many of its mechanical responses. 
ii. Large scale anisotropy In other types of cancellous bone the plates may be 
considerably longer, up to several mm, and these are preferentially oriented in one 
direction. Another type consists wholly of sheets, forming long tubular cavities which 
interconnect through holes in their walls. 
The type made of cylindrical struts with no preferred orientation is found deep in bone, 
well away from any loaded surface, or where the direction of loading is multiaxial, while 
the more oriented types are found just underneath loaded surfaces where the direction of 
loading is uniaxial. 
iii. Porosity This is the proportion of the total specimen volume not occupied by 
bone tissue. Porosity varies from almost complete, to 70 % (Gibson 1985). Bone with 
less than 70 % porosity is classed as cortical bone. 
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Figure 2.4.1 The rod and plate structure of cancellous bone (from Gibson, 1985) 
Carter and Hayes (1977) compared the structure of cancellous bone to that of open-celled 
plastic foams and aerated concrete, as in such materials apparent density is generally the 
most important factor affecting the material properties. Hvid (1988) found the compressive 
strength and stiffness of cancellous bone to be primarily dependent on the apparent density, 
trabecular architecture and strength of the bone material. Significant correlations between 
apparent density and compressive strength of trabecular bone were also found by Galante et 
al'. (1970) and Favenesi et al. (1984). Multiple regression analysis to relate the elastic z: I 
modulus of cancellous bone and explanatory variables gave the most important variable as 
apparent density (Hodgkinson and Currey, 1990a). The str-ucture of cancellous bone was zn 
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also important, since the number of connecting struts between trabeculae (connectivity) was 
highly correlated with apparent density. Further work showed (Hodgkinson and Currey, 
1990b) that it was possible to explain 93% of the variance in Young's modulus in 
cancellous bone using apparent density, mineral volume fraction, fabric and connectivity, 
the last two being measures of the trabecular architecture. ZD 
2.4.2 Density of Cancellous Bone 
Apparent density is defined as the mineralised tissue mass per total volume of the sample 
and is a function of the amount of bone present, while real density is defined as the density 
of the solid bone material, and the actual density is the total specimen mass per total 
specimen volume (Sharp et al., 1990). There is a broad consensus that trabecular 
architecture is the most important single factor in determining both compressive strength 
and elastic modulus of cancellous bone and that these properties are functions of apparent 
density. Rice et al. (1988) prepared a statistical analysis of the pooled data from previous 
papers and showed both the modulus of elasticity and strength to be proportional to the 
square of the apparent density of the tissue and therefore proportional to one another. 
Galante et al. (1970) showed that relatively small changes in porosity induced major 
changes in the compressive strength of cancellous bone. A model showing the Young's zD 
modulus of cancellous bone to be approximately proportional to the third power of the 
density and the strength to be proportional to the fourth power of the density was devised 
by McElhaney et al. (1970). Cancellous bone cubes from human femora were tested in 
tension and compression (Carter et al., 1980) and the relationship between bone strength 
and apparent density was found to be similar for specimens tested in the two loading 
modes, the Young's moduli also being comparable. The energy absorption capacity was 
significantly lower for tensile specimens than for compressive bone specimens since the Z. ý 
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fractured bone fragments separated and thus absorbed little energy after the initial failure. 
The shear strength of bovine bone was found to be proportional to the apparent density to 
the exponent 1.65 (Stone et al., 1983). Natall and Meroi (1989) showed elastic modulus 
values for trabecular bone, ranging between 0.06 and 3 GPa, to be strongly dependent on 
density, whose average value was given as 0.3 Mgm-3. Quantitative computed 
tomography was used by Hvid et al. (1989) to evaluate the relation of apparent density to 
the Young's modulus and ultimate strength and it was suggested that a power law 
regression model is preferable to a linear model. In general it has been found that higher 
densities are associated with increased strength and stiffness, parallel with the effects of 
increased mineral content and decreased porosity (Riggs, 1990). Turner et al. (1990) also 
found the elastic constants to be proportional to the apparent density squared or cubed. 
Data on the compressive properties of cancellous bone cubes over a large range of densities 
were assessed by Hodgkinson and Currey (1992) and it was found that the exponent 
relating the Young's modulus to density is close to quadratic. 
2.4.3 Quasi static properties 
The mechanical behaviour of cancellous bone is similar to that of other cellular materials 
such as polymeric foams (Gibson, 1985) and its mechanical properties depend on apparent 
density, cell wall properties and cell geometry. The stress-strain curve of cancellous bone 
in compression has three distinct regimes of behaviour like all elastic-plastic foam materials 
(Gibson, 1985): 
At small compressive strains cancellous bone is linear elastic. In cells with asymmetric 
structure the rods and plates intersect at each others' mid-points, causing elastic bending of 
the cell walls. In cells with columnar structure the rods and plates stack on top of one 
another and deformation in the longitudinal direction is by axial compression of the cell 
walls. In the transverse direction the cells do not align and deformation is by bending 
similar to asymmetric cells. At higher strains, the cell fails by elastic buckling, by plastic 
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yielding or by brittle fracture. If the rod and plate elements have a high length to thickness 
ratio, failure is by elastic buckling, but at low slenderness ratios wet specimens yield 
plastically. Failure progresses at an approximately constant load until the cells compact, 
enabling the cell walls to touch, then the resistance to load increases giving rise to the final 
steeply rising portion of the stress strain curve; this is known as densification. As the 
density of cancellous bone increases the walls become thicker, the Young's modulus and 
compressive strength increase and the strain at which the cells compact decreases, 
decreasing the length of the collapse stress plateau. 
Static and dynamic loading regimes in cancellous bone were analysed (Pugh et al., 1973a 
and b) with the aim of developing a quantitative model for cancellous bone by 
approximating trabecular geometry with a hypothetical network of compact bone. It was 
concluded that bending and buckling of trabeculae is a significant deformation mechanism 
during elastic loading and that the stiffness of a trabecular system is highly dependent on its 
arrangement. It was also noted that fatigue fracture of suitably oriented trabeculae is 
inevitable in normal walking, and stiffness varies considerably with the lateral position 
across the subchondral plate. Sharp (1988) and Hodgkinson and Currey (1990) both state 
that there is a very strong linear relationship between the compressive strength of 
cancellous bone and the Young's modulus. 
Odgaard et al. (1989) studied the strain distribution in cylindrical cancellous bone 
specimens using digitised images of the specimens and saw that in the pre-failure phase the Zý ;.,., 
middle third was strained significantly less than the edges. End effects meant that the 
stress-strain relation would be dependent on the geometry of the specimen i. e. the height to 
width ratio. 
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Figure 2.4.2 Compressive behaviour of cancellous bone of three different densities (from 
Gibson, 1985) 
Linde and Hvid (1989) investigated the effects of constraint on cancellous bone specimens 
in mechanical testing. Specimens have lost the surrounding bone which normally 
constrains their lateral expansion, the surface of the specimen may be damaged by 
machining, the axial deformation measurement is usually performed between points on the 
test column and there are two inter-faces between the specimen and the loading plates where 
friction induces constraints to lateral movement. The Young's modulus of unconsn-m-ined 
cancellous bone specimens was increased from 409 ± 53 MPa to 598 ± 68 MPa when 
surrounded by a steel constraint. 
Cancellous bone is difficult to test in tension because of the problems of gripping the 
specimen ends without crushing them and so is usually tested in compression. However, 
methods for tensile testing of bovine cancellous bone were developed by Kaplan et al. 
(1985), based on porous foam technology. The mean ultimate tensile strength was 
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significantly lower than the mean ultimate compressive strength and the difference was not 
related to density differences between the test groups. It was also observed that the 
force/displacement curve for bovine cancellous bone tested in tension was different to that 
obtained by Carter et al. (1980), but this was attributed to structural differences between 
human and bovine cancellous bone; bovine cancellous bone being isotropic and generally 
denser and so behaving in a more brittle manner than human bone. Keaveney et al. (1994 
developed bovine dumbbell specimens with the ends glued into brass holders thus enabling 
the specimens to be gripped and tested in either tension or compression and the strain 
measured with an extensometer on the gauge length. Keaveney et al. (1994J compared zn Zý 
measurements of tensile and compressive yield strengths and yield strains of cancellous 
bone from bovine proximal tibiae and found that the mean tensile yield strength was 30% 
lower than the compressive yield strength, but the difference between individual values of 
the tensile and compressive yield strengths and moduli increased linearly with increasing 
density. Mechanical and ultrasonic tests on single trabeculae and geometrically equivalent 
cortical bone specimens were performed by Rho et al. (1993). The average Young's 
modulus of trabeculae measured mechanically was 10.4 GPa (S. D. 3.5), significantly less 
than that of cortical bone at 20.7 GPa (S. D. 1.9). The mean trabecular Young's modulus 
measured by ultrasound was also significantly less than that of cortical bone, suggesting 
that cortical and cancellous bone are not the same material. 
Cancellous bone exhibits topographical differences in its mechanical properties. 
Cancellous bone from the human distal femur was tested in compression by Ducheyne et 
al. (1977) and it was found that the compressive strength of the bone decreased with 
increasing distance from the joint. When testing human femoral cancellous bone, Martens 
et al. (1983) found large variations in compressive strength and Young's modulus within 
and between samples. The mechanical properties in both normal and osteoarthritic bone 
were found to be higher in weight bearing areas than in non weight bearing areas by Tanner 
et al. (1988). Compression testing of healthy and osteoarthritic femoral heads (Hoffman et 
-48- 
al., 199 1), revealed that regions of high compressive strength were located in the supero- 
medial portions of the head where the load was greatest. The properties of cancellous bone 
taken from the proximal tibia (Goldstein et al., 1983) varied by as much as two orders of 
magnitude from one location to another. Hvid et al. (1983) found that while the 
compressive strength of tibial cancellous bone varied from bone to bone, topographic 
patterns within each bone were consistent, with the medial condyle having the highest 
compressive strength and the intercondylar area the lowest . 
Galante et al. (1970) found that the compressive strength of vertebral bone was 
significantly higher along the superior-inferior axis than along the other two planes. The 
Young's modulus and yield strength of 5mm cubic specimens from the human femur were 
measured in three perpendicular directions (Brown and Ferguson, 1980), and the modulus 
was found to be substantially reduced when measured in directions other than those of 
habitual weight-bearing. Goldstein (1987) attributed topographical variation to functional 
remodelling as dictated by Wolff s Law. Topographic differences in the mechanical 
properties of human bone are summarised extensively by Evans (1973). 
2.4.4 Viscoelastic Behaviour 
Specimens of human cancellous bone show an increased ability to withstand compression 
at lower strain rates (Galante et al., 1970). Purely elastic behaviour is seen up to 2 Hz 
cyclic loading (Pugh et al., 1973a). At low rates of deformation the viscoelastic nature of 
cancellous bone is controlled by the ultrastructure of bone but at higher strain rates the 
deformation is dependent on the viscous flow of the marrow (Carter and Hayes, 1977). 
When a load is applied to cancellous bone, as with cortical bone, there are two 
components, an elastic element which is due to hydroxyapatite and a viscous element 
which undergoes Newtonian deformation and may be due to the collagen content of the 
bone or the effect of viscous flow due to bone marrow (Gibson, 1985). Sasaki et al. 
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(1993), however, considered the stress relaxation process in bone to be governed by 
viscoelastic properties of the collagen matrix fibre alone. 
2.4.5 Damage Characteristics of Cancellous Bone 
The damage characteristics for human and bovine bone have been shown to be similar, 
despite differences in microstructure (bovine bone is plexiform whereas human bone is 
Haversian) (Fondrk et al., 1988), suggesting that damage of cancellous bone must be 
dominated by mechanical behaviour at the ul tra- structural / sub-osteon level. Age related 
bone fragility may be due to a combination of systemic metabolic factors, which could 
relate to uniform reductions in density, and mechanical factors (Keaveny et al., 19940. 
These may relate to either too much or too little stress protection of damaged cancellous 
bone. The authors suggest that repair of damaged cancellous bone occurs due to an 
acceptable 'window' of stress protection, and that complete resorption occurs on either side 
of this window due to two different mechanisms. If stress is too high, excessive relative 
movement of the fractured and cracked trabeculae would inhibit the healing process and 
eventually lead to fragmented trabeculae that would be resorbed. If stress is too low, 
resorption would occur in accordance with Wolff s Law. This hypothesis is based on 
observations of changes in modulus and strength that occurred when bovine cancellous 
bone was loaded in compression to various strains below its elastic range. 
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2.5 Effects Of Arthritic Conditions on Mechanical Properties 
Osteoarthritis and its effects on the mechanical properties of cancellous bone have been 
investigated by many workers. Osteoarthritic cancellous bone has been found to be less 
stiff than normal bone (Wixson et al., 1987) and this may be due to stiffening of the 
subchondral plate, leading to unloading of the underlying cancellous bone, which then 
remodels to become less dense and stiff. It was also noted that the bone tissue from 
patients with rheumatoid arthritis was less strong than normal bone but that osteoarthritic 
bone had a similar strain to failure as normal bone, suggesting that it was like normal bone 
tissue morphologically. The subchondral plate in all types of osteoarthroses was found to 
be significantly softer than normal bone (Bonfield et al., 1987). The trabecular bone of 
rheumatoid arthritis patients was shown to be significantly softer than both normal and 
osteoarthritic bone (Sharp, 1988). The disease process of osteoarthrosis was found to be 
confined to the weight bearing areas of the bone and increased the mechanical properties in 
those areas (Tanner et al., 1988). However, Deligianni et al. (199 1) when investigating the 
cancellous bone from human female femoral heads found all mechanical properties to be 
higher in all areas in osteoarthritic bone than in normal bone. 
Ochronotic arthropathy of the hip joint, a very rare inflammatory condition, was studied by 
Tanner et al. (199 1). The mechanical properties were found to be normal, the actual 
density was increased and the microhardness of the subchondral plate was decreased. 
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2.6 Osteoporosis 
The cumulative risk of fracture in post-menopausal women with reduced bone mass is 
between 10 and 20 times greater than that of women of the same age in whom bone mass is 
essentially unchanged compared to pre-menopausal values (Ortolani and Trevisan, 1993). 
The estimated annual cost of care of osteoporotic patients in the United Kingdom is at least 
E500 million (SCRIP publication 'Recent Trends in Research and Treatment of 
Osteoporosis' 199 1). The impact of post-menopausal osteoporosis is expected to reach 
epidemic proportions during the early part of the next century as the population ages 
(Lindsay, 1990). The commonest fracture sites are the femoral neck, the wrist (Colles' 
fracture of the radius) and the lower thoracic and upper lumbar vertebrae ('crush' 
fractures). Fracture of the long bones, for example the proximal femur, occurs on average 
around 15 years later than vertebral compression fractures, which may be related to the fact 
that proportionally more of the femoral neck is composed of cortical bone compared with 
the vertebrae (Revell, 1986). Hip fractures can be separated into two types - femoral neck 
cervical and trochantenc. Faulkner et al. (1993) found that hip axis length, a geometrical 
measurement, predicts hip fracture independently of age and bone mineral density. 
However, Squillante and Williams (1993), assessing the radiographic mineral density of 
medial femoral cortices from osteoporotic and non-osteoporotic age-matched females, 
found that differences in porosity, osteon number and osteon mineralisation between the 
fracture group and the normal controls were altered in the periosteal region. It was 
suggested that it was these changes in the cortical bone which ultimately resulted in fracture 
of the femoral neck since, in a fall on the hip, the wall of the medial femoral cortex would 
be placed in bending with the maximum stress occurring subperiosteally. In this case 
therapeutic agents which would exert an effect on cortical as well as cancellous bone would zn 
be desirable. 
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2.6: 1 Pathophysiology 
Osteoporosis is the most common metabolic bone disorder. It is characterised by an 
increased tendency to fractures, due to a lower bone mass than is normal for a given age 
and sex. It was noted by Amprino (1958), among others, that senile osteoporotic bone is 
as hard as non-nal adult bone, implying that there is a decrease in the amount of bone 
material in the skeleton but that what is left is normal bone material. No alteration in 
mineralisation has been found, which differentiates the disorder from others such as 
osteorrialacia, in which there is a decrease in mineralisation. Osteoporosis has been defined 
as occurring in those patients having a bone mass more than two standard deviations below 
the mean found in young healthy adults, or in age- and sex-matched controls (Revell, 
1996). There are various classifications of osteoporoses. Primary osteoporosis refers to 
the occurrence of the condition among the ageing population where a secondary 
predisposing condition cannot be found (Lindsay and Cosman, 1992) and includes post- 
menopausal osteoporosis and the osteoporosis of ageing. Secondary osteoporoses can be 
caused by endocrine disorders such as hypercorticosteroidism, hyperthyroidism, liver 
disease, some tumours, and by certain drugs such as corticosteroids, thyroxin and 
anticonvulsants. 
2.6.1 (i) Hormonal factors in post menopausal ! 2steoporosis 
Lindsay and Cosman (1992) report that increased calcium transport both into and out of the 
skeleton is a primary change that occurs after oestrogen deficiency. The oestrogens play a 
major role in limiting bone resorption as the osteoblasts have oestrogen receptor sites, and 
osteoclasts have calcitonin sites. It is believed that in some way calcitonin mediates the 
action of oestrogen in controlling bone resorption. Oestrogen deficiency is thought to lead 
to bone loss by decreasing calcium intestinal uptake and activating PTH secretion which Z: ý 
stimulates osteolysis (Revell, 196b). Oestrogen deficiency makes the C cells of the thyroid 
less responsive to serum calcium stimulation. Since the C cells produce calcitonin its 
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production is reduced and thus the control of osteoclastic bone resorption is reduced. 
Another effect of oestro, (,,, en is to inhibit the synthesis of interleukin 6, a cytokine that 
stimulates the development of osteoclasts. The activity of oestrogen on a variety of 
physiological systems acts to balance resorption and formation and maintain bone mass. 
Oestradiol and oestrone levels are low in both osteoporotic and normal post-menopausal 
women, but oestrone levels are much lower in the former. Vitamin D metabolism appears 
to be normal (Davies et al., 1977) and PTH levels may be normal (Riggs et al., 1973) or 
raised (Gallagher et al., 1980). Sims et al. (1994) reported that serum oestradiol levels 
may affect circulating PTH levels, the calcium set point for PTH secretion, or bone 
sensitivity to PTH, but that it has also been shown that circulating PTH levels are 
unchanged after the menopause and that the relationship between serum ionised calcium 
and PTH is also unchanged. Calcitonin inhibits osteoclastic activity and its absence may 
therefore result in bone loss, but workers disagree on whether calcitonin levels are 
decreased in osteoporosis (Chesnut et al., 1980). It has been reported in several case - 
control studies that subjects with hip fractures have lower concentrations of 25- 
hydroxyvitamin D but the findings have not been consistent (Khaw and May, 1995). Bone 
density was shown to be positively related to serum 25-hydroxyvitamin D levels in a recent 
UK population based study, which supports the hypothesis that 25-hydroxyvitamin D 
status may be an important determinant of bone density, even in normal people, by 
regulation of PTH levels. At least some of the decrease in bone density with age may be 
associated with an increase in serum PTH levels, which in turn is attributed to the decrease 
in 25-hydroxyvitamin D concentration that occurs with age. 
The effect of parathyroidectomy on femoral trabecular bone volume, thickness and spacing, 
and biochemical markers of bone turnover in the ovariecton-lised (OVX) rat was studied by 
Sims et al. (1994) who found that parathyroidectomy failed to prevent post-OVX bone 
loss; the only difference was a small decrease in trabecular thickness in the OVX rats which 
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was not detected in animals subjected to both ovariectomy and parathyroidectomy. 
However, Hillam et al. (1995) found that trabecular bone mineral density (BMD) measured 
by peripheral quantitative computed tomography (pQCT) in the proximal tibia was 
significantly lower in OVX rats than in OVX rats which had also undergone 
thyroparathyroidectomy. 
2.6.1 (ii) Nutritional factors in post menopausal osteol2orosis 
There is decreased intestinal calcium absorption with increasing age and increased urinary 
calcium excretion (Heaney et al., 1978a), and this is even greater in osteoporotic than non- 
osteoporotic post-menopausal women (Gallagher et al., 1973 and 1979). Rico et al. 
(1993) found that 36 women with vertebral osteoporosis showed significantly decreased 
levels of biochemical markers of nutrition (transferrin, prealburnin and retinol binding- 
protein) compared with 40 healthy women of a similar age. A study of the diets of 
perimenopausal women showed that their average calcium intake was below the US 
recommended daily limit so they were in negative calcium balance (Heaney et al., 1978b). 
An increased calcium intake is required after the menopause in order to stay in calcium 
balance partly due to altered intestinal calcium absorption and partly to less efficient 
conservation of calcium. A high protein diet induces calciuria and brings about negative 
calcium balance (Heaney and Recker, 1982) and this calciunc effect is probably related to 
increased production of organic acids. Rather than being an indirect effect of decreased 
serum 1,25 dihydroxyvitamin D or of intestinal resistance to its action, intestinal calcium 
malabsorption in post-menopausal osteoporotic women may be linked directly to low 
circulating oestrogen (Aijmandi et al., 1993). Immunocytochemistry was used to localise 
oestrogen receptors in intestinal cells, Northern blot analysis to demonstrate the presence of 
oestrogen receptor mRNA in the cells and functional studies to demonstrate that oestrogen 
acts directly on intestinal cells to promote calcium uptake. Other possible but poorly 
understood nutritional factors include a high caffeine intake (leading to increased urinary Zý' 
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calcium excretion) and alcoholism, in which bone mass is reduced and calcium intake is 
usually below the recommended daily allowance. 
2.6.1 (iii) Exercise factors in post menol2ausal osteol2orosis 
Bone mass increases during youth to reach a maximum at age 20 - 30 (Fleisch, 1993). The 
amount forined is mostly (80 - 90%) determined by genetics and the remainder is 
influenced by nutrition, exercise and hormonal factors. A study by Mosekilde et al. in 
1994 using a rat model found that while exercise alone had no significant effect on 
biornechanical parameters, it reduced cortical-endosteal bone resorption and had an anabolic 
effect on femoral cortical bone and vertebral bodies, which was seen mainly in the 
attainment of peak bone mass. Westerlind et al. (1995) found that 11.5 months after OVX 
in rats, cancellous bone area was decreased in the metaphysis but was unchanged in the 
epiphysis of OVX animals, despite a comparable increase in bone turnover in the two 
regions. In their experiment to investigate the respective roles of oestrogen deficiency and 
mechanical strain on cancellous bone balance, strain was reduced or increased by 
weightlessness or exercise. It was found that weightlessness resulted in increased loss of 
cancellous bone from the epiphysis while treadmill exercise prevented loss of cancellous 
bone from the OVX metaphysis. 
2.6.1 (iv) Mechanisms of bone loss 
At about 40 years of age, cortical bone mass starts to decrease slowly, cancellous bone loss 
having begun several years earlier. The total loss, in women, will be about 50% of 
cancellous and 35% of cortical bone (30% and 20%, respectively, in men). The first 
component of this loss is thought to be a continuous slow loss of similar magnitude in men 
and women, affecting cortical and cancellous bone to the same extent but beginning earlier 
in cancellous bone. It is thought that this may be due to a low calcium intake coupled with 
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vitamin D deficiency, impaired synthesis of vitamin D or a resistance to its action. This 
deficiency will lead to hyperparathyroidism and an increase in resorption from the skeleton. 
The second component of bone loss is the post-menopausal loss of oestrogens which leads 
to decreased inhibition of osteoclastic activity and formation and a consequent increase in 
bone resorption. This effect particularly involves cancellous bone and displays an 
exponential function with maximal activity at the beginning. Fleisch (1993) suggests that 
any prevention therapy such as oestrogen treatment should therefore begin as soon as 
possible. The rate of bone loss in women suffering from post-menopausal osteoporosis 
ten years after the menopause began was found to be less than I% per year (Ruegsegger et 
al., 1981). Since the bone mass in these women was significantly reduced from normal it 
was concluded that the women must have experienced a phase of rapid bone loss, 
presumably immediately after the menopause. The rapid losers as a group have been found 
to have low body fat, low plasma oestrone and oestradiol and raised urinary 
hydroxyproline and calcium. Ryan et al. (1993) when measuring BMD at the lumbar 
spine, femoral neck, trochanteric region and Ward's triangle using Dual Energy X-ray 
Absorptiometry (DEXA) in women with osteoporotic vertebral collapse estimated that the 
majority of bone loss had occurred before the onset of fractures. The bone loss of post- 
menopausal osteoporosis is most apparent in cancellous bone and this seems to be a 
generalised skeletal effect (Ruegsegger et al., 198 1), however it has been reported by 
Lindsay and Cosman (1992) that the cancellous bone, of the vertebral bodies is especially 
sensitive to declining sex hon-none production. With ageing the apparent density of 
cancellous bone decreases, healing microfractures become more abundant and the 
trabecular architecture changes (Hodgkinson and Currey, 1990a). Mechanical properties 
have been found to be higher in the major weight bearing areas of the cancellous bone of 
the femoral head of human females in both normal and osteoporotic groups (Deligianni et 
al., 1991). In all areas, mechanical properties were lower in the osteoporotic than in the 
normal uoup. 
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Yoshida et al. (1991 ) suggested that cancellous bone loss occurs primarily in the regions 
where mechanical stress on trabeculae is decreased . In osteopaenia induced by oestrogen 
deficiency in rats, almost all the trabeculae from the central metaphysis, where mechanical 
stress is small, disappeared while in the peripheral area little difference was observed 
between OVX and sham operated rats 9 months after surgery. The proposed mechanism 
for the loss of rod trabeculae, based on the observed appearances, is that the rod thins in its 
middle and is perforated; the edge is tapered just after perforation but gradually rounds and 
decreases in height, forming a rounded spike-like shape, and finally flattens. 
Monier-Faugere et al. (1993) stated that the increased erosion depth in ovario- 
hysterectornised beagles given control injections proves that the early rapid bone loss after 
cessation of ovarian activity is related to increased osteoclastic activity. The statistical study 
of Prince et al. (1993) on bone density and the hydroxyproline / creatinine ratio (a measure 
of bone resorption) showed that bone resorption had a significant effect on bone density 
even 10 years after the menopause, and also that renal function may account for some of 
the variance in hip bone density with activity effects being more marked at the ankle which 
is a site of greater loading. The increased depth of resorption pits created by osteoclasts is 
also thought to be an important determinant in pathogenesis of the architectural damage of 
bone (Parfitt et al., 1983). Mast cells and their products have been suggested as playing a 
role in bone resorption in osteoporosis, as Fallon et al. (1983) have reported increased 
numbers of mast cells in the bone marrow of post-menopausal osteoporotic patients from 
normals. 
There is some evidence that cancellous bone loss, especially age related loss, involves 
preferential destruction of cross struts leading to increased anisotropy with decreased 
density. Miller and Wronski (1993) found a greater separation of trabeculae in the 
proximal humeral metaphysis in OVX rats than in controls after 18 months. The remaining 
trabeculae were mostly longitudinal rods, whereas in controls there were rods and plates. Z-- 
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The bone loss following OVX was similar to the bone loss during the first reproductive 
cycle in rats. The long term changes in the structure of cancellous bone in OVX rats were 
thought to be consistent with a decreased need for a skeletal mineral store for reproduction 
and the trabeculae that did remain would maintain the bone's structural capacity. The 
compressive strength of cancellous bone depends more on preservation of connections 
between the structural elements than on the amount of bone present (Pugh et al., 1973). 
Mosekilde et al. (1987) have also noted that horizontal trabeculae disappear with age 
leaving a predominance of vertical trabeculae which leads to dornination of elastic buckling 
and bending forces instead of compressive forces. They suggest that during the treatment 
of osteoporosis, restoration of the trabecular lattice by fori-nation of new trabeculae would 
be much more effective than an increase in bone mass due to thickening of existing 
trabeculae. Observation of iliac bone samples from normal and osteoporotic subjects 
showed a reduction in trabecular bone volume (TBV) in normal subjects with increasing 
age mainly due to a reduction in plate density with no significant decrease in plate thickness 
(Parfitt et al., 1983). The further reduction in TBV seen in those with osteoporotic 
vertebral fracture was due mainly to a further reduction in plate density. Only in patients 
with hip fracture did trabecular thinning contribute substantially to the loss of volume. 
From this they inferred that the normal loss of trabecular bone with age occurs mostly by a 
process that removes entire structural elements leaving the remaining trabeculae more 
widely separated but only slightly reduced in thickness. Since all trabeculae are made by Z: ý 
endochondral ossification, new trabeculae cannot arise after epiphyseal fusion and so an 
increase in TBV can only occur by thickening of the existing trabeculae. This is the reason 
that sodium fluoride treatment can lead to increased spinal bone density without a 
significant decrease in vertebral fracture rate (Riggs et al., 1990). The situation becomes 
more complex with the suggestion of Recker et al. (1992) that many clinical syndromes of 
excess skeletal fragility involve defective microdamage repair since the fragility is out of 
proportion to the decrease in bone mass. 
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2.6: 2 Treatment 
Current treatments include hormone replacement therapy, calcitonin, calcium supplements 
or bisphosphonates. However, all these drugs act only to inhibit the resorption of bone 
and not to stimulate its formation, so while they are valuable for preventing the disease 
from progressing further they still leave the patient with a bone mass which is below 
normal and therefore prone to fracture. Fluoride and PTH are the only agents known to 
have an anabolic effect on human bone. 
2.6.2 (i) Hormone Revlacement Thera 
Hormone replacement therapy (HRT) reduces bone resorption, although the mechanism is 
unclear. Whilst further bone loss can be prevented, HRT cannot restore bone mass. Some 
consider that HRT only has major benefits if started no more than 6-8 years after the 
menopause begins. If started early enough and sustained it can reduce rates of bone loss Z: ý 
for as long as 9- 10 years. However, in some patients it may cause nausea, giddiness, 
headaches and bloating and there may also be a small risk of endometrial or breast cancers. 
Heaney et al. (1978b) showed that the bone remodelling rate increased slightly but 
significantly after the menopause, that resorptive activity predominated and that low doses 
of an oestrogen can prevent these post-menopausal changes. Workers, including Gallagher 
et al. (1973), have shown improvements in calcium balance in both normal and 
osteoporotic post-menopausal women with oestrogen therapy and that post menopausal 
bone loss is prevented by oestrogen administration (Lindsay et al., 1976). Improved 
Vitan-dn D serum levels in osteoporotic women have been seen with oestrogen therapy 
(Gallagher et al., 1980) and an increase in immunoreactive PTH levels was also observed. 
From this it was concluded that enhanced calcium absorption was due to raised vitamin D 
produced by stimulation of renal Ict-hydroxylase by PTH. 
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In OVX rats treated with 2 ýLg oestradiol valerate per week for 8 months the body weight of 
the rats was normalised and the endosteal bone resorption induced by OVX was halted 
(Mosekilde et al., 1993). Oestrogen treatment of both OVX and intact rats tended to reduce 
the rate of periosteal bone formation. Keeting et al. (1991) reported that oestrogens had no 
direct effect on proliferation and differentiation of normal human osteoblast cells. Although 
these cells were derived from non-nal adult bone and expressed oestrogen receptors, they 
failed to respond to treatment by an increase in DNA synthesis. It was concluded that 
oestrogens act primarily to decrease bone resorption, not to modulate its formation. A high 
dose of oestrogen (500 ýtg per week) was found to inhibit bone resorption and stimulate 
bone formation in the ovariectomised niouse (Bain et al., 1993). Treatment of 
ovariectornised rats with diethylstilbestrol (an oestrogen) led to increased bone formation at 
the periosteum, with no increase in bone resorption, and increased bone resorption at the 
endosteum with no increase in bone fon-nation (Turner et al., 1993). This evidence argues 
against the hypothesis that the increase in bone formation in ovariectomised rats is 
secondary to changes in bone resorption in cortical bone. 
In an investigation of the effect of different hormone replacement therapy regimens on the 
mechanical properties of rat vertebrae (Chachra et al., 1995) oestrogen plus interrupted 
norethindrone, a progestin, was the only regime that gave the bone a significantly greater 
compressive modulus and density than bone from the non-OVX group. The other 
oestrogen / progestin combinations increased only the bone density of the treated animals 
above that of OVX animals. 
There have been few trials of progestogens alone but the results of such trials suggest that Zý 
they could have potential for preventing bone loss. There are some situations where Zý 
progestogen would be desirable instead of combined HRT e. g. breast malignancy. Zý Z: ' 
Unfortunately, progestogen treatment is also associated with adverse blood lipoprotein 
patterns. Progesterone was found to increase secretion of Insulin-like Growth Factor-2 
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JGF-2) in human osteoblastic cells (Tremollieres et al., 1992). IGF-2 is the most 
abundant growth factor found in human bone; it is produced by osteoblasts and has been 
shown to stimulate bone cell proliferation and type I collagen synthesis, and probably acts 
in the local regulation of bone turnover. Tremollieres et al. (1992) speculate that t-I 
progesterone deficiency may play a role in the impairment of the coupling response that 
occurs at menopause via reduced secretion of IGF-2. 
2.6.2 (ii) Vitamin D 
High dose administration of vitamin D (between 10 and 100 ýtg kg body weight-1 day-1) 
greatly reduces the osteoclast number as well as osteoblastic bone formation in the iliac 
bone. It has been suggested that trabecular disruption, or perforation, starts early in the 
post ovariectomy period and the process may not necessarily be associated with increased 
numbers of osteoclasts, therefore in order to prevent disruption or perforation of the 
trabeculae after ovariectomy it is not sufficient to only suppress osteoclast development but 
to also suppress existing osteoclastic activity and stimulate osteoblastic bone fon-nation. Z: ý 
Vitamin D was administered to beagles for 31 months after OVX (Yamaura et al., 1993). 
Torsional tests were perfon-ned on the femoral diaphyses and compression tests on the 
lumbar vertebrae with and without their cortical shells. It was found that the mechanical 
properties of the cancellous bone were reduced, stiffness more markedly than strength. 
The mechanical properties of the cortical bone were not affected. Optimal Vitamin D3 
administration preserved structural and mechanical properties of cancellous bone after 
Ovx. 
2.6.2 (iii) Bisl2hosphonates 
Bisphosphonates are compounds characterised by two C-P bonds. If the two bonds are on 
the same carbon atom the compounds are called geminal bisphosphonates. 
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Figure 2.6.1 Generalised structure of bisphosphonate molecule, where X and Y are ions 
which are specific to each bisphosphonate 
Geminal bisphosphonates have the strongest activity in vivo and are the only ones in 
clinical use. A large number have been synthesised, each with its own physicochernical 
and biological characteristics. Bisphosphonates whose effects have been investigated in 
humans and which are now on the market are I -Hydroxyethylidene- 1,1 -bisphosphonic 
acid (HEBP), Dichloromethylenebisphosphonic acid (Cl2MBP) and Alendronate. 
Bisphosphonates have high affinity for solid-phase calcium phosphate and can prevent 
precipitation of calcium phosphate from clear solution even at very low concentrations. 
They also block the transfon-nation of amorphous calcium phosphate into hydroxyapatite, 
delay the aggregation of apatite crystals into larger clusters and slow down their 
dissolution. In vivo they have been shown to prevent experimentally induced calcification 
of arteries, kidneys, skin and heart and to inhibit the calcification of bioprosthetic heart 
valves (Casey er al., 1972). Bisphosphonates also inhibit bone resorption. In growing 
rats they block the degradation of both bone and cartilage, and thereby arrest remodelling of 
the metaphysis which becomes club shaped and radiologically more dense. They prevent 
OVX-induced osteoporosis (Wink et al., 1985). It was originally hoped that the decreased 
resorption seen with bisphosphonate therapy would be accompanied by a rise in calcium 
balance and in the mineral content of the bone but this is only a small and very transient 
effect; after a certain time formation drops almost in parallel with the change in resorption, 
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probably due to the coupling between resorption and fon-nation, thus the main effect of 
bisphosphonates is on bone turnover. 
Bisphosphonates may affect calcified tissues exclusively because of their strong affinity for 
calcium phosphate, which means they are cleared very rapidly from the blood into bone. 
Whenever bone is resorbed, the compounds are released into solution in free form or 
bound to apatite, reaching a high local concentration, and are taken up by the resorbing cell. 
One dose of bisphosphonates may thus be active for long periods. 
Cyclical etidronate therapy has led to a significant increase in lumbar bone mineral mass 
although a plateau is reached after 1-2 years. The rationale for using cyclical therapy 
(otherwise known as ADFR - activate, depress, free, repeat) is to induce activation of bone 
remodelling followed by suppression of bone resorption and a subsequent treatment-free 
interval during which bone formation should occur. Steiniche et al. (1991) observed that 
patients treated with cyclical etidronate therapy showed a significant decrease in bone 
activation frequency and final resorption depth. 
Between 20 and 50% of 1-Hydroxyethylidene-1,1-bisphosphonic acid (HEBP) absorbed is 
localised to bone, the rest is excreted rapidly in the urine. In 1987 Storm et al. reported that 
400mg day- I of HEBP given for 2 weeks in every 15 weeks over 2 years led to a 6% 
increase in trabecular bone in the spine of postmenopausal women while controls lost 5% 
vertebral trabecular bone mass. OVX rats treated with HEBP every other day for 92 days 
were prevented from developing worse osteopaenia at doses of 2mg kg-1 and 4 mg kg-1 but 
at 8mg kg-1 bone loss was increased, due to severe inhibition of mineralisation (Togari et 
al., 199 1). 
Alendronate is a potent bisphosphonate, which selectively inhibits bone resorption whilst 
impairing bone formation and mineralisation. It binds preferentially to bone resorption 
surfaces and, as the osteoclasts begin resorbing, it is released locally during acidification 
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and inhibits their action. Preliminary histomorphometric data has shown normal bone 
histology in patients treated with alendronate for up to I year. In a six month study of the ZD 
effects of alendronate treatment of postmenopausal women with osteopaenia (Rossini et al., 
1994), all indices of bone turnover were significantly suppressed in the first 3 months and 
a further decrease was observed in the next 3 months. Pre-treatment bone turnover values 
were reached 6-9 months after cessation of treatment but BMD had become statistically 
significant only after a further 6 months, implying that the positive bone balance induced by 
alendronate may continue long after treatment has stopped. 
Animal studies have shown that the gain in bone mass is associated with an increase in 
bone strength. Lauritzen et al. (1993) showed that combined prostaglandin and alendronate 
treatment of OVX rats for 25 days after a2 month treatment free interval post - OVX 
increased the mechanical strength of the rat femoral shaft compared to non-OVX animals, 
as measured by 3 point bending. Seedor etal. (1991) also observed reduced bone loss 
following OVX in rats due to alendronate treatment, the total amount of compound given 
being more important than the frequency of administration in terms of magnitude of effect. 
2.6.2 (i v) Parathyroid Hormone (PI 
PTH therapy has been shown not to improve body calcium balance but to lead to up to 70% 
increased trabecular bone volume in the iliac crest (Reeve et al., 1980). When combined 
with calcitonin therapy Hesch et al. (1989) observed an increase in vertebral cancellous 
bone of 12%. S lovik et al. (1986) found that PTH combined with vitamin D increased 
calcium absorption. 
Sogaard et al. (1994) demonstrated a highly significant increase in femoral neck tý ýn 
biornechanical competence after ovariectomy and treatment with parathyroid hormone 
(PTH) in rats, whereas treatment of OVX animals with oestrogen or risedronate did not 
produce a significant increase in bone strength. The same effect was observed by t, Z: ' 
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Mosekilde et al. (1994) in vertebral bodies. Riggs (1991) reported that PTH stimulates 
bone formation in low doses, leading to an increase in cancellous bone mass in adult rats 
and dogs. Rixon et al. (1994) suggest that PTH may stimulate bone growth by activating 
adenyl cyclase. Intermittent treatment of a foetal rat calvarium model with PTH led to an 
increase in local production of IGF- I whereas continuous treatment did not. They also 
noted cortical bone loss (Canalis et al., 1989). Shen et al. (1993) combined PTH with 
oestrogen treatment of OVX rats. Treatment began 1,3 or 5 weeks after surgery and was 
continued for 4 weeks. When administered in a preventive mode (after I week) either PTTI 
or oestrogen alone preserved trabecular bone volume as well as trabecular connectivity. In 
the curative mode (3-5 weeks post-OVX) either treatment alone prevented further loss of 
connectivity and TBV. The combined treatment gave a 300% increase in node to node strut 
length and 106% increase in TBV % with respect to the beginning of treatment. Wronski et 
al. (1993) left OVX rats untreated for 4 weeks after the operation. Treatment with 
oestrogen or a bisphosphonate alone was then found to depress bone turnover and prevent 
additional cancellous bone loss from occurring during treatment, but these therapies failed 
to restore bone in the OVX rats to control levels. OVX rats treated with PTH alone 
exhibited a marked increase in bone formation leading to augmentation of cancellous bone 
mass up to a level twice that of untreated sham-operated rats. Concurrent treatment of 
OVX rats with PTH and oestrogen as well as PTH and the bisphosphonate also effectively 
reversed cancellous osteopenia in OVX rats but did not appear to be more beneficial to the 
oestrogen-deplete skeleton than treatment with PTH alone. 
Intermittent PTTI therapy at low and high doses was given to rats which had not been 
ovariectornised (Ejersted et al., 1993). The biornechanical properties showed a dose related 
increase in strength and stiffness of femora tested in 3 point bending and this increase in z: ' 
mechanical strength corresponded with a 9-12% increase in the cross sectional area of the Z-- 
femoral diaphyses. Injecting PTH at increasing intervals after ovariectomy was found to 
stimulate growth and mineralisation of femoral trabecular bone at the same rate in both 
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control and OVX rats (Whitfield et al., 1995). Cross sectional area and volumetric cortical 
BMD at midshaft and distal metaphyses of rat femurs were enhanced by PTH over control 
values (Ferretti et al., 1995). However, the bending fracture force of the femoral shafts 
was increased by PTH over control values only in bones that were also overloaded, which 
suggests that although PTH exerts a strong anabolic effect on rat cortical bone, the z: I 
mechanical effect is only transient and depends on an interaction with physical activity. 
2.6.2 (v) Fluoride 
Although the effect of fluoride as a stimulus for the mitotic division and multiplication of 
osteoblastic cells has been confin-ned in many experiments on animal models, the target cell 
that is stimulated to divide has not yet been clearly identified. The reaction of fluoride with 
the hydroxyapatite of bone mineral leads to the formation of fluoroapatite by the 
substitution of hydroxyl ions by fluoride ions. Fluoroapatite has a larger crystal size and 
lower solubility than hydroxyapatite. Mechanically defective bone may be formed and 
some patients do not respond to the treatment at all. This is because fluoride has a very 
narrow therapeutic window and it is difficult to maintain the blood fluoride level above the 
therapeutic threshold (95 ng ml-1) without exceeding the toxic threshold (190 ng ml-1). 
Pak (1989) argues that these problems can be overcome by the intermittent application of a 
slow release preparation of Sodium Fluoride (NaF) combined with an optimally 
bioavailable calcium supplement - in this way the vertebral bone mass may be increased 
without a reduction in radial or femoral bone mass. The new bone formed with this 
treatment was lamellar in appearance, adequately mineralised and apparently mechanically 
intact. The majority of patients responded favourably with an increased bone mass and 
decreased fracture rate. Abnon-nal bone mineralisation was observed in three patients with 
osteoporosis after fluoride treatment compared to their bone mineralisation before treatment 
(FratzI et al., 1994). The mineral structure was observed by a combination of 
backscattered electron imaging and small angle X-ray scattering and was characterised by zý r-I Zý 
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the presence of additional large crystals which were presumed to be located outside the 
collagen fibrils. 
In one study it was found that if 60 - 75 mg of fluoride was given daily together with 2! 5 
calcium and oestrogen the vertebral fracture rate was virtually eliminated (Riggs et al ., 
1982). In most studies fluoride increases the bone density of the axial skeleton including 
the iliac crest in which density is increased 60 %, but this may be at the expense of 
peripheral bone mass (Lindsay and Cosman, 1992; Gutteridge et al., 1984; Riggs et al., 
1990) . However, up to 
fifty percent of patients who are treated with fluoride may 
experience gastric and rheumatic side effects such as nausea, vomiting, diarrhoea, 
gastrointestinal bleeding, sNiDovitis of the large joints of the lower limbs and worsening of 
any existing gout. It is possible that other doses or preparations of fluoride such as zn 
monofluorophosphate may be more effective but may also be associated with a greater 
toxicity (Lindsay and Cosman, 1992). 
Jowsey et al. (1972) found that in order to restore bone mass in osteoporotic subjects 
without producing X-ray or microscopic evidence of fluorosis a treatment of 50mg NaF 
and at least 900mg calcium daily was required plus 50,000 units of vitamin D twice a 
week. Fluoride therapy increased cancellous BMD but reduced cortical bone BMD and 
hence led to increased skeletal fragility (Riggs et al., 1990). A marked decrease of 45% in 
cancellous bone strength of iliac crest biopsies was observed after five years of sodium 
fluoride treatment in osteoporotic patients (Sogaard et al., 1994), compared to an expected 
decrease of 6% in untreated osteoporotic patients. Treatment of 23 patients with 
osteoporosis and vertebral fractures with continuous calcium citrate and intermittent slow 
release NaF promoted a small but significant increase in trabecular connectivity (Zerwekh et Z: ' 
al., 1994). 
Bone powder from fluoride treated animals has higher density fractions than that from 
untreated animals and fluoritic bone is less subject to dissolution (Pak, 1989). 14 day old 
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chicks were treated with NaF (4.2 mM in drinking water) for 2 weeks (Lundy et al., 1986) 
and an increase in bone forming surface was observed in the tibial metaphysis, with no Zý 
change in the number of osteoblasts per length of forming surface. Ewes were treated with 
either I or 5 mg kg-Iday-I and no calcium supplementation (Chavassieux et al., 1991). z: I ZD 
The bone fluoride content was significantly increased in the higher dose group, serum 
calcium and phosphorus were significantly reduced, there was a significant increase in 
osteoid perimeter and area and there was an increase in bone formation rate in both groups. 
A stimulatory effect on the differentiation of osteoblasts was implied but fluoride was also 
found to prolong the lifespan of osteoblasts that had reduced cellular activity. The increase 
in trabecular bone mass was attributed to an unbalanced coupling in bone remodelling in 
favour of bone formation. 
2.6.2 (vi) Other Treatments 
Wallach et al. (1993), in a review of the effects of calcitonin on bone, conclude that as well 
as inhibiting bone resorption, calcitonin enhances osteoblastic bone formation, which 
makes it a more desirable treatment than many of the drugs which are only anti-resorptive, 
because these also inhibit bone formation due to the coupling of resorption and formation. 
Calcitonin receptors have been demonstrated in osteoblast-like cell lines (lida-Klein et al., 
1992). Nasal spray calcitonin treatments are currently undergoing clinical trials. 
Nandrolone Decanoate (an anabolic steroid) was used to treat ovariectomised rats at a dose 
of I mg every 14 days by Aerssens et al. (1993) for 6 months, after which a significant 
increase in periosteal bone formation, femoral length, cortical and trabecular bone mineral 
content and density and torsional stiffness and strength were observed. Treatment did not, 
however, restore all the changes induced by ovariectomy to the level of the intact controls. 
Short term oral phosphate has been shown to activate bone remodelling in the 
ovariectomised beagle model (ShLnd Anderson, 1993) following the release of Z71 
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parathyroid hormone. It was suggested that the increase in the number of bone remodelling 
units forryfing may make it possible to produce a positive skeletal balance by the application 
of another drug at this stage. 2: ý 
Prostaglandin E2 has been shown to increase rat cortical bone mass when given 
immediately after ovariectomy (Hua Zhu Ke et al., 1993). 
Strontium has been used as an uncoupling agent to increase bone formation to sham- 
operated levels while inhibiting bone resorption in OVX rats (Marie et al., 1993). Bone zD 
ash and bone mineral content were restored to sham values, but the trabecular bone volume 
was only restored by 30 - 36% whereas with oestrogen treatment it was corrected by the 
full 46% lost after ovariectomy. 
2.6: 3 Animal Models for the investigation of bone biomechanics 
2.6.3 (i) Rabbits 
There seems to be no published literature regarding the use of rabbits of any species as a model 
for post-menopausal osteoporosis. However, female New Zealand White (NZW) rabbits have 
been used as a model for drug-induced osteoporosis (Turan et al., 1994). The animals were 
divided into four groups - one was an untreated control group, one was given heparin, one was 
given heparin plus calcitonin, and the fourth was given heparin, calcitonin and tamoxifen. After 
8 weeks, humeri, femora and tibiae were removed and tested in 3-point bending. There were 
no significant differences observed in bending stiffness between any of the groups except the 
tamoxi fen -treated group which showed a 2% increase in stiffness, compared to controls. Male 
NZW rabbits have also been used as a model for regional osteoporosis occurring under internal 
fixation plates and its treatment with calcitonin (Karachalios et al., 1992). It was found that 
long term administration of calcitonin increased the mechanical properties of both fractured and 
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intact bones, and reduced the porosity of the cortex under the plate. It has also been shown that 
Vitamin D (Nakamura et al., 1992) and fluoride (Lees and Hanson, 1992) increase bone density 
in New Zealand White rabbits. 
2.6.3 (ii) Rats 
According to Wunder et al. (1979) 
"In studies where experimental treatment influences size, experimental values of 
bending strength should not be compared to thosefrom rats of the same age and differing 
size or to thosefrom rats of the same size and differing age" 
Kalu (1991) states that the OVX rat is not known to develop fractures although it loses 
bone following OVX but that the model is sound if the mechanisms of bone loss following 
OVX are similar to those occurring in the human post-menopausal female. Two rat models 
have been proposed; the aged Tat model in which skeletally mature rats of 12 months old 
are ovanectomised, and the mature rat model, in which sexually mature rats of 3 months 
old are ovariectomised. Both these models relate to early post-menopausal bone loss rather 
than post-menopausal osteoporosis. Miller and Wronski (1993) noted that the loss of 
central metaphyseal trabecular bone following OVX was similar to that observed during the 
first reproductive cycle, indicating that the central metaphyseal bone of female virgin rats is 
more metabolically active and may not be essential for structural integrity. They suggest 
that during normal loading conditions, although the mechanical strength of the bone 
material may be reduced, the structural capacity of the skeleton is not compromised and 
there is no increase in spontaneous fractures. The aged orchiectornised male rat has also 
been used as a model for human osteoporosis (Vanderschueren et al., 1993). 
Despite their small size and irregular shape, a number of studies have already been 
perfon-ned on the mechanical properties of bone in the ovariectomised rat model of post- 
menopausal osteoporosis. 
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Compression of lumbar vertebral bodies is a popular test for the OVX model, having been 
used by Guy et al. (1993), Ammann et al. (1993), Shen et al. (1993), Bagi et al. (1993), 
Katsumata et al. (1993), Diez- Perez et al. (1993), Mosekilde et al. (1993), Lauritzen et al. 
(1993) and Toolan et al. (1992). In the non-OVX rat, compression testing was carried out 
on vertebral bodies by Salem et al. (1989), on cancellous bone from the proximal and distal 
humerus by Simkin et al. (1989) and on I mm dried cross sections from the femoral 
midshaft by Kimura et al. (1979). 
In the vertebrae, it took six months for a decrease in trabecular bone volume and nine 
months for a reduction in biomechanical properties to occur, according to Mosekilde et al. 
(1993). However, Guy et al. (1993) report a reduction in ultimate compressive stress of 
the vertebral body after only six weeks. The difference may be related to Mosekilde's use 
of Wistar rats which were ovariectomised at the age of 3 months, whereas Guy used rats of 
an undefined strain ovariectomised at the age of 6 months. Wronski et al. (1989a) worked 
with Sprague-Dawley rats ovariectornised at 3 months, and saw a decrease in trabecular 
bone volume 3 months after the operation. Toolan et al. (1992) also worked with Sprague- 
Dawley rats ovariectomised at 3 months and found that it took 10 months before any 
reduction in biornechanical properties was seen. Lauritzen et al. (1993) using Sprague- 
Dawley rats ovariectornised at 6 months reported a decrease in trabecular bone volume after 
2 months without any reduction in mechanical properties. Thus, a reduction in vertebral 
trabecular bone volume may be seen any time between 2 and 6 months after ovariectomy, 
and a reduction in mechanical properties becomes apparent between 6 and 12 months. 
However, Mosekilde et al. (1993) do not feel that the findings of their study may be 
extrapolated directly to humans because the loading forces on the vertebrae are different Z: ý 
(rats being quadripedal), the trabecular bone pattern is different and rats have less bone Z: ' 
remodelling than larger animals. These reservations are equally applicable to all the other Zn Zý 
studies on rat vertebrae. 
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Loading of the femoral head parallel to the axis of the femoral shaft to bring about failure of 
the femoral neck has been done in the OVX rat by Zhiqi et al. (1993), Kharode et al. 
(1993), Lauritzen et al. (1993) and Toolan et al. (1992). In the studies by Toolan et al. 
(1992) and Lauritzen et al. (1993), the femoral shaft was embedded in poly-methyl- 
methacrylate up to the level of the lesser trochanter and a preload of between 5 and 15 N 
was applied before testing. A small steel cup lined with PMNIA approximating to the size 
and shape of the acetabulum transmitted the load from the crosshead to the femoral head at 
a rate of 60mm min-1. These studies detected no significant reduction in the breaking 
strength of the femoral neck after ovariectomy, however the other two studies (Zhiqi et al., 
1993; Kharode et al., 1993) showed femoral neck strength to be a sensitive indicator of the 
reduction in biornechanical properties following ovariectomy. The reason for the 
discrepancy could lie in the method of specimen preparation, since, by embedding the 
femoral shaft up to the lesser trochanter the forces on the neck are altered because the load 
is no longer transmitted down the cortical bone of the femoral shaft. The steel cup used to 
transmit the load to the head of the femur was also said to be impinging on the greater 
trochanter. These tests were performed in conjunction with histomorphometrical analyses 
(Kharode et al., 1993). Peng et al. (1994) inserted rat femurs perpendicularly and tightly 
into a polymeth y1methacryl ate plate and loaded them at 0.155 mm s- I with a concave 
compressing head 2.5 mm in diameter. The maximum load was used for comparison 
between groups. It was found that OVX induced 17.7 and 30.7 % decreases in maximum 
failure load after 8 and 18 weeks respectively. In the non - OVX rat, measurement of 
femoral neck strength to failure by loading the femoral head parallel to the femoral shaft 
was performed at strain rates ranging from 2mm. min-1 (Martin, 1990) to 254 mm min-1 
(Hou et al., 1990 and 1993). In the work of Hou et al. the femoral diaphysis was 
cemented in a cylindrical brass tube to the level of the lesser trochanter and attached to a 
stainless steel base before the load was applied. Zernicke et al. (I 99S looked at the effects 
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in cantilever bending of a high fat, hich sucrose diet on the biomechanical properties of the Zý' ZD 
femoral neck. 
A decrease in the strength of the femoral neck to failure was observed by Zhiqi et al. (1993) 
after 6 weeks and by Kharode et al. (1993) after 8 weeks. The study by Lauritzen et al. 
(1993) found no reduction in breaking strength of the femoral neck three months after 
ovariectomy in 6 month old Sprague-Dawley rats. Toolan et al. (1992) found no reduction 
in femoral neck strength ten months after ovariectomy in 3 month old Sprague-Dawley rats. 
A modified cancellous bone strength indentation test was compared with compression tests Zý 
on cancellous bone and 3 point bending tests on whole bones of OVX rats (Shen et al., Z-1 
1993). It was concluded that the indentation test preferentially measured the mechanical 
strength of the trabecular bone and may possibly have illustrated the effects of cancellous 
bone architecture on mechanical strength. In the non-OVX rat, a penetration test was 
performed on the trabecular bone of the distal femur and proximal tibia by Martin (1990). 
A probe, 1.59mm in diameter with a rounded tip, was forced into the metaphysis from the 
medullary canal at a rate of 2mm min-1. The force at 2.5mm of penetration was taken as 
the penetration strength. Z: ý 
In the proximal tibia, Wronski et al. (1989b) saw a significant reduction in trabecular bone 
volume one month after 3 month old Sprague-Dawley rats were ovariectomised. A similar tý 
change was observed by Hagino et al. (1993) two months after ovariectomy in 6 month old tl 
Sprague-Dawley rats, and by Yoshida et al. (199 1) nine months after ovariectorny in 7-8 
month old Wistar rats. 
Bone from the femoral diaphysis seems to be the only cortical bone that has been studied in 
the OVX model. Lauritzen et al. (1993) reported a reduction in the bending strength of the 
midshaft 2-3 months after ovariectomy in 6 month old Sprague-Dawley rats, but Z-) 
Barengolts et al. (1993) found no such difference three months after ovariectomy in 9 Zý 
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month old Sprague-Dawley rats, and Toolan et al. (1992) found no change ten months after Z: ' 
ovariectomy in 3 month old Sprague-Dawley rats. Danielsen et al. (1993) working with 6 
month old Wistar rats, found no differences in real or apparent density, ash weight or wall 
thickness of the femur after 18 months. 
2.6.3 (iii) Other models 
Although the rapidly growing chick skeleton differs in some respects from the remodelling 
human skeleton with osteoporosis, chicks, like humans, respond to NaF treatment with an 
increase in bone forming surface, suggesting that the young chick may be a useful model to z! ) 
study the mechanism of fluoride stimulated bone formation in vivo (Lundy et al., 1986). 
Ewes have a bone remodelling process comparable to that of humans, however with any 
orally-adnýiinistered drug their ruminant status must be taken into account (Chavassieux et 
al., 1991). 
Beagles have been used as a model for post-menopausal osteoporosis and subsequent 
bisphosphonate treatment (Monier-Faugere et al., 1993). 36 beagles were ovario- 
hysterectornised (OHX) and 12 were sham-o erated. The OFIX dogs given vehicle alone p6 
showed reduced trabecular bone volume associated with increased erosion depth and 
decreased serum vitamin D levels. The bisphosphonate prevented bone loss at a 
concentration of 1ýtg kg body weight-I and an increased erosion depth and vitamin D serum 
level was seen at 0.3 ýtg kg body weight-I with no osteornalacia. Bone turnover was 
reduced only at concentrations above 104g kg body weight-1. The long oestrous cycle in zn 
dogs may make bone less sensitive to either natural or artificial oestrogen loss indicating 
that a long observation period may be essential in these studies (Yamaura et al., 1993). 
The changes observed in cancellous bone are similar to those seen in human post- 
menopausal osteoporosis. 
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Mosekilde et al. (1993) ovariectornised four month old minipigs and restricted their calcium 
intake. After 6 months a model of primarily cancellous osteo*nia was seen associated 
with increased resorptive cell function at the level of the remodelling unit and trabecular Zý' 
plate perforation. They suggest that this model may be valuable for studying the 
consequences of alteration of remodelling and resorptive cell function on cancellous bone 
microstructure and strength and may be useful for modelling certain aspects of post- Z: ' 
menopausal bone loss in women. They quote the following figures relating to changes in 
vertebral bone mineral density in other animal models after ovariectomy: beagles -8.5% 
after 12 months, macaques -9% after 6 months and baboons -6% after 6 months. 
It has recently been suggested (Li et al., 1994) that the ferret may be a better small animal 
remodelling species than the rat because its remodelling is similar to that in humans, 
however, little work has been undertaken with this species to date. 
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CHAPTER THREE 
Materials and Methods 
3.1. Rabbits 
3.1.1 Animal Preparation 
Sixteen New Zealand White rabbits, aged 18 weeks, were surgically ovariecton-lised Zý 
(OVX) and twenty left intact as age-matched controls. The animals were housed in 
individual cages and allowed free access to standard laboratory food ("Standard Rabbit 
Diet" from Special Diets Services) and tap water. 
Four intact rabbits were killed immediately as baseline controls, then at one, three, six and 
twelve months after ovariectomy, four rabbits from each group were killed. Body weight 
at time of sacrifice was recorded and serum oestradiol was measured by 
radioimmunoassay. The kit used was an oestradiol double antibody kit from Diagnostic 
Products Corporation with a detection limit of 4.9 pg ml-1 and a precision measurement of 
8% coefficient of variation on inter-assay analysis. 
Femora, humeri and metatarsals were removed from all the animals, wrapped in tissue 
paper soaked in full-strength buffered Ringer's solution, and stored at -20*C until testing 
took place. 
3.1.2 Specimen Preparation 
Metatarsals Whole metatarsal bones from both feet of each animal were embedded at 
both ends in slow-setting epoxy resin (Epofix from Struers Ltd) which creates a maximum 
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exotherm of approximately 50'C. The size of the moulds was minimised to reduce the 
quantity of resin and thus the exotherm. The diaphyses of the bones were kept wet while 
the resin set by being wrapped in tissue paper and soaked in full-strength buffered Ringer's 
solution. The epoxy blocks were then cut on a bandsaw to provide 5 mm square blocks, 
which could be held in the pneumatic clamps of the testing machine 
Epoxy-embedded 
epiphysis to - 
enable gripping 
metata 
Figure 3.1.1 Schematic diagram of metatarsal specimen 
Humeri Using a bandsaw, the distal humerus was removed proximal to the 
epicondyles and olecranon fossa, and the heads of all the humeri were removed at the 
surgical neck. Cylindrical plugs of cancellous bone 5mm in diameter were trephined from 
the humeral heads and their ends made plane - parallel to a length of 5mm using an EXAKT 
diamond bladed bandsaw with micrometer control of the specimen holder. The bones were 
kept wet during trephining with full strength buffered Ringer's solution and with water 
when using the EXAKT. Two perpendicular diameters and the specimen length were 
measured using Vernier calipers, and the actual density (Sharp et al., 1990) determined zn 
before testing. The diaphyses and the cylindrical cancellous bone specimens were again 
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wrapped in tissue paper soaked in full-strength buffered Ringer's solution and stored at 
-20'C until testing. 
5mm 
5mm 
Figure 3.1.2 Dimensions of a cylindrical cancellous bone specimen 
Femora Usinc:,, a bandsaw, femoral heads were removed distal to the lesser 
trochanter and the distal femur was removed proximal to the condyles. Cylindrical plugs of 
cancellous bone 5mm in diameter were trephined from the intercondylar area, their ends 
made plane parallel with a length of 5mm and they were treated as for the humeral head 
specimens. The femoral diaphyses and cylindrical cancellous bone specimens were 
wrapped in tissue paper soaked in full-strength buffered Ringer's solution and stored at 
-20'C. 
3.1.3 Mechanical testing of rabbit bone specimens 
All mechanical testing was done on an NITS 858 Bionix system at room temperature 
keeping the specimens wet with full-strength buffered Ringer's solution. The load cell was 
25 kN - 30ON-m calibrated down to 10 kN, 100 N-m, giving a measured accuracy better 
than ±50 N and ± 0.5 Nm. The test control and data logging was controlled by MTS 
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TeststarO with MTS TestwareO running on a Compaq 486 DX Prolinea desktop personal 
computer. 
Torsion 
The metatarsals were tested in torsion at an angular deformation rate of I* s- 1. Data was 
collected at 5Hz. Torque, stiffness and angular deformation to failure were calculated. For 
only the 12 month timepoint specimens, two perpendicular diameters and the thickness of 
the cortical bone at the fracture site were measured with Vernier calipers. Shear stressc at 
the point of fracture was calculated: 
T 
D, +D2 
T=-, ýý( 
2) (3.1.1) 
271 
tl + t2 Dl 
- 
t, )(D2 
_ 
t2 (2222 
where T= torque at a given point t: l 
DI = maximum diameter of bone 
D2 --'ý minimum diameter of bone 
tj = maximum wall thickness of bone 
t2 = minimum wall thickness of bone 
The extrinsic stiffness i. e. the stiffness of the whole bone was calculated: 
Extrinsic stiffness 
where I= length between grips 
ultimate angular deformation in radians 
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Extrinsic (structural) stiffness = GJ (3.1.3) 
where G= intrinsic stiffness i. e. stiffness of the bone material 
J= polar moment of inertia, or I, z, and was calculated by: 
4 7U2 
ti + t2 D, 
_ 
tj 
2_ (D2 t2 )2] 
2 
)[( 
2222 
j2 
D, D2) 
n(DI 
+ D2 tl + t2 1+0.27 222 
22D, D2 
22 
DI, D2, tj and t2 are as defined in equation 3.1.1. 
Intrinsic stiffness (G) was calculated by: 
Extrinsic Stiffness 
(3.1.5) 
Four point bending 
Femoral and humeral diaphyses from each animal were tested to failure in 4 point bending. 
The bone was positioned and the load applied so that the anterior aspect of the bone failed 
in tension. The lower contact points of the four point bending rig were 40 mm and the 
upper contact points 20 mm apart (Fic,, ure 3.1.3). 
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The vertical displacement rate was 0.05mm. s-1. Flexural strength, stiffness and ultimate 
deformation to failure were calculated. For the 12 month timepoint the thickness of the 
cortical bone and the maximum and minimum diameters of the bone at the point of fracture 
were measured using Vernier calipers. These were used to calculate bending stress and Zý' 
modulus of elasticity: 
Fa. D2 
2_ 
lxx 
7E DID32 
ixx = -1 
4L 16 
Stiffness = 
CY 
Al 
L dy 
2 
_(DI _tl)(D2 - t2 
)3 
22 
where F =applied force 
a= half the difference between the internal and the external bending spans 
dy = vertical displacement of upper loading points during test 
and DI, D2, tj and t2 were as defined for equation 3.1.1 
(3.1.6) 
(3.1.7) 
(3.1.8) 
(3.1.9) 
-82- 
5mm 
40mm 
Figure 3.1.3 Schematic drawing of the 4 point bending jig 
Compression 
Cylindrical specimens of cancellous bone from the proximal humerus and distal femur were 
tested in compression between polished stainless steel platens in a bath filled with full- 
strength buffered Ringer's solution at a strain rate of 0.001 mm s-1. Ultimate compressive 
strength, strain to failure and compressive stiffness were calculated. 
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20mm 
Deten-nination of Material Densities 
After mechanical testing, a fragment of cortical bone from each metatarsal was weighed, 
wet in air (Ma), on an electronic balance accurate to 0.01 mg. Each piece of bone was then 
re-weighed suspended in distilled water (MwI). The density is given, using Archimedes' 
principle, by the equation 
Pactual - 
Ma 
X Pwater Ma - Mwi 
(3.1.10) 
Determination of cancellous bone density was more detailed as three densities needed to be 
calculated - the actual, real and apparent densities (Sharp et al., 1990). The actual density 
was determined before mechanical testing using the same method as for metatarsal sample 
density. After testing, the specimens were defatted in trichloroethylene in an ultrasound 
bath for 4 hours. The specimens were thoroughly rinsed in tap water and rehydrated in 
distilled water under vacuum for a further four hours. The specimens were weighed 
suspended in water again (Mw2), then placed in an absorbent tissue sleeve and centrifuged 
at 6000 rpm for 20 minutes. They were then weighed in air (Mh) and the real and apparent 
densities calculated: 
Preal ý 
Mh 
X Pwater Mh - Mw2 
Papparent =_ 
Mh 
X PwaLcr Ma - Mwl 
(3.1.11) 
(3.1.12) 
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Apparent density is a measure of the porosity of the sample whilst real density refers to the 
density of the bone matenal itself. Actual density is the density of the cancellous bone 
specimen with the intertrabecular spaces filled with marrow, fat etc. 
Finally, the fragments were ashed at II 00*C for 18 hours in an oven with air extraction and 
bone n-: iineral content was obtained by weighing r. ý * 
Student's t-test was used to compare the mean values of the ovariectomised and control 
groups at each time point and inter-group variation with time. 
3.2 Rats 
3.2.1 Three point bending - pilot study 
Before the treatment study was set up, a pilot study was performed using rat bones from a 
study carried out at Zeneca Pharrnaceuticals. These bones had been stored at -20*C as for 
the rabbit bones. This was done in order to assess the difficulties involved in mechanically 
testing very small irregularly shaped bones and to resolve these difficulties where possible. zn 
Three point bending of tibias was chosen as the literature precedent suggested it was a 4ý1 
widely used test for which comparative data was available. 
Right tibias from all animals were cleaned of all soft tissue, wrapped in tissue paper soaked 
in full-strength buffered Ringer's solution and stored at -20*C until testing took place, prior 
to which they were left to thaw overnight. The tibias were placed on the lower loading 
points of the three point bending rig with the tibial ridge downwards. The lower loading 
points were 20 mm apart and the centre of the upper loading point was 10 Mrn from the 
centre of each of the lower loading points. The lower loading points were moved towards 
the upper loading points at a rate of 0.1 mm s-1 and the test was stopped when failure 
occurred. Bending strength and energy absorbed to failure were recorded and bending 
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stiffness calculated from the force- displacement trace obtained during the test. The bones 
were kept wet throughout the test with full-strength buffered Ringer's solution. 
3.2.2 Animal Preparation 
Female rats from the Alderley Park strain aged 13 - 15 weeks (230 - 260 g) were divided 
into two groups of 60 and 125 animals. The first 60 were sham-operated and the 
remaining 125 were ovariectomised under Saffan anaesthesia using the dorsal approach 
from a single skin incision. The rats were allowed free access to standard laboratory food 
("Porton Combined Diet" from Special Diets Services) and tap water. 
Oestroaen 10 sham and 55 OVX animals were involved in the oestrogen study. After 
the operation the animals were left in their cages overnight to recover. Oestradiol-3- 
benzoate was used dissolved in absolute alcohol at I mg ml-1. The 10 sham and 25 OVX 
animals acting as vehicle-treated controls were given daily sub-cutaneous (s. c. ) injections 
of 0.2 ml Arachis Oil, the vehicle in which oestrogen was dissolved for the treatment 
groups. Of the remaining 30 OVX animals, 10 were given daily s. c. injections of 0.03 ýtg Zý 
oestradiol-3-benzoate (a low dose) in 0.2 ml Arachis Oil, 10 received a medium dose of 0.1 
ýLg oestradiol-3-benzoate in 0.2 ml Arachis Oil and 10 received a high dose of 0.3 ýIg 
oestradiol-3 -ben zoate in 0.2 ml Arachis 011. Treatment was continued daily for 6 weeks 
and the animals' health was monitored by daily examinations and weekly weighing, then 
the animals were killed humanely. 
PTH Because PTH is an anabolic agent, treatment did not begin until 7 weeks following 
OVX, when osteopaenia had developed. 10 sham and 20 OVX animals were killed 
immediately as baseline controls. Treatment then began on the remaining 40 sham and 50 
OVX animals. PTH 1-34 (human) was used dissolved in Dulbecco's phosphate buffered 
saline containing 0.1% bovine serum albumin. 10 sham and 200VX acting as vehicle- Z: ý 
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treated controls received daily s. c. injections of 0.2 ml Arachis Oil. 10 sham and 10 OVX 
received 5 ýLg/kg body weight PTH in 0.2 ml Arachis Oil. 10 shams and 10 OVX received z: I Z: ' 
5 ýtg/kg body weight PTH plus 0.3 ýtg oestradiol-3-benzoate in 0.2 ml Arachis Oil. 10 
shams and 10 OVX received only 0.3 4g oestradiol-3 -ben zoate in 0.2 ml Arachis Oil. 
After 5 weeks of treatment, during which health was monitored by daily examination and 
weekly weighing, all the animals were killed humanely. 
Tibias and femurs were removed from all the animals and stored at -20*C until specimen 
preparation took place. 
3.2.3 Specimen Preparation 
Peripheral Quantitative Computed Tomoual2hy (12QCT) 
Prior to specimen preparation for mechanical testing, distal right femurs and proximal right 
tibias were scanned non-invasively in a STRATEC XCT - 960 A PQCT 
TM, supplied by 
Stratec: Medizintechnik, Germany. Before scanning took place, a Quality Assurance scan 
was done using hydroxyapatite embedded in a water - equivalent plastic which was known zn 
to be significantly more dense than the predominantly fatty tissue found in bone. This 
phantom was calibrated to the COMAC European forean-n phantom, with an adjustment 
made for the difference between the phantom's plastic and the non-mineral tissues found in 
the forearm bones. Previous work on pQCT of OVX and sham rat bonesin vivo and in 
vitro gave an in vitro precision of 1.9% for total BNIID and 2.4% for trabecular BMD 
(Breen et al., 1996). Total and trabecular BMD in vivo and in vitro were highly correlated 
(correlation coefficients were 0.8 and 0.91 respectively) but cortical measurements showed 
a poor correlation. The X-ray tube was run at a voltage of 47 kV and a current of less than Z: I 
0.3 mA. Scan time was 2.5 minutes for an initial scout scan and 2.5 rriinutes for a full CT 
scan. During a CT scan, the X-ray source rotated to 15 tomographic positions over 180*. 
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Signals were picked up by 5 detectors. In order for trabecular and cortical bone to be 
quantified separately, a threshold value was set to separate bone from background noise 
and artifacts. These were 0.4 , cm-3 for trabecular bone and 0.7 g cm-3 for cortical bone. Zý, 
The bone was placed in a specially designed plastic tube and surrounded by full strength 
buffered Ringer's solution. The tube was closed and placed in a specially designed holder 
on the scanning platform of the STRATEC so that the intercondylar notch of the femur or 
the tibial crest was always aligned with a mark on the top of the holder. A scout scan was 
performed to determine the position of the joint surface. The X-ray source was then moved 
7mm back from the joint surface so that the epiphyseal growth plate was not included in the 
scan. Three contiguous lmm slices were scanned, at 6mm, 7mm and 8mm from the joint 
space. Total, trabecular and cortical BMD and % trabecular bone were recorded for each 
slice. 
Femora 
Left femurs were autoclaved. and all soft tissue removed, as well as cartilage from the distal 
condyles and the femoral head. The volume of the bone was determined by Archimedes' 
principle using water. The bones were then ashed at 700*C for 18 hours in a muffle 
furnace and the ash weight measured. Bone Mineral Density was calculated: 
BMD = 
Ash weight 
Ma - Mwi 
Ma and M, I are as defined in equation 3.1.10 
Right femurs were cleaned of soft tissue and the femoral head cartilage removed. The 
diaphysis of the bone was cut with a scalpel midway between the distal end of the third 
trochanter and the knee. The proximal portion was wrapped in tissue paper soaked in full 
strength buffered Ringer's solution and stored at -20'C until testing took place. zn 
-88- 
Tibias 
Right tibias were cleaned of soft tissue and the knee cartilage removed. Allowing for the 
blade thickness of 0.3 mm, the bone was positioned in a small bone saw (Isomet) such that 
the proximal 2mm was removed. The bone was then moved 5mm forward using a 
micrometer on the specimen holder, and another cut made parallel to the first one. These 
5mm thick metaphyseal slices were wrapped in tissue paper soaked in full-strength 
buffered Ringer's solution and stored at -20T until testing took place. 
3.2.4 Mechanical testing of rat bone specimens 
Femoral neck The prepared femur specimens were placed in a brass cylindrical tube at a 
valgus angle of 6' to a steel base, and secured with a screw and brass clamp. The steel 
base was placed on a piece of Teflon, 25mm thick, on a steel plate on the crosshead of an 
Instron. A brass cylinder with a hemispherical indentation on the inferior surface and with 
the outer surface removed so as not to touch the greater trochanter was secured to the 
Instron load cell. The specimen was positioned such that the femoral head lay inside the 
circular indentation but no load was applied (Figure 3.2.1). A vertical load was then 
applied to the femoral head by the upper cylinder at a vertical displacement rate of 0.01 MM 
s-1. Load to failure of the femoral neck was recorded as the most clinically relevant 
parameter. When this method was used by Leichter et al. (1982) on human cadaveric 
femurs, the corTelation between bone mineral content per unit volume, obtained using a 
commercial bone mineral analyser made by Norland-Cameron, producers of the STRATEC 
pQCT, and the breaking force of the femoral neck was found to be much higher (r = 0.68, 
p<0.001) than that between the Singh index and breaking force (r = 0.49, p>0.01) but not 
as high as the correlation between breaking force and bone density measured using the 
Compton-scattering technique (r = 0.81, p<0.001). When the strength of the rat femoral 
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neck was tested in a similar manner by Peng et al. (1994), but with the vertical force Z: ý 
applied parallel to the diaphysis of the bone, a positive correlation was observed between 
femoral neck strength and tibial ash weight (r = 0.54, p<0.01) or femoral trabecular bone Zý 
volume (r = 0.51, p<0.01). 
It 
V, 
Figure3.2.1 The femoral neck fracturý jig, with femur in place 
Tibial cancellous bone The prepared tibial specimens were placed with the distal end 
downwards on a steel plate on the loading platform of a Schenk Trebel testing machine. A Zý 
needle of 1.5 mm projected diameter with a pointed, 90* cone tip and the needle shaft 
milled to 1.3 mm was secured to the crosshead and used to indent the cancellous bone in 
the cranio-caudal direction at a velocity of I mm s-1 (Figure 3.2.2). A trace was obtained 
of penetration force versus penetration depth. This is similar to the method used by Hvid et 
-90- 
al. (1983) for their osteopenetrometer nieasurements of cancellous bone strength in the 
human knee during surgery. zn 4: 1 
Figure 3.2.2 The tibial indentation jig with tibial specimen in place 
-91 - 
CHAPTER FOUR 
Results 
4.1 Evaluation of Mechanical Properties of Rabbit Bones 
Values for all mechanical test parameters are displayed in table 4.1.1, for density 
measurements in table 4.1.4 and for serum oestradiol levels in table 4.1.5. The values 
given are the group mean ± the standard error of the mean (SEM). In all the figures, 
data is plotted as mean ± SEM. Asterisks indicate the significance level of the 
difference between the means: *p<0.05, ** p<0.025, *** p<0.01. 
No asterisks indicate that the difference is not statistically significant. 4n 
4.1.1 Torsion - Metatarsals 
Figure 4.1.1 shows that first metatarsals displayed significantly greater torsional 
strength than 2nd metatarsals in both groups at all time points except 12 month 
controls, where 2nd metatarsals were significantly stronger than the 1st (p < 0.05). 
First metatarsals also displayed significantly higher structural stiffness than 2nd for 
both groups at all timepoints (Figure 4.1.2). Zý 
Between 6 and 12 months there was a large increase in torsional strength of the lst and 
2nd metatarsals in both control and OVX animals, bone from the I st metatarsal OVX 
group being stronger than bone from controls at 12 months (p < 0.025). First metatarsal 
stiffness was significantly higher in OVX than controls at I month (p<0.05) and again 
at 12 months, but this difference was not significant. 
A reduction in torsional strength and stiffness was seen in the second metatarsal 12 
months following OVX (Figures 4.1.1 and 4.1.2). There was also a large increase in Z: ' 
2nd metatarsal structural torsional strength between 6 and 12 months, with control 
strength becoming higher than OVX strength at 12 months, but not significantly so. 
Control stiffness was also higher than OVX stiffness at 12 months but again the Zý 
difference was not significant. 
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When the differences in the sizes and shapes of the I st and 2nd metatarsals were taken 
into account and the material shear strength and moduli were calculated using equations 
3.1.1 to 3.1.3 at the 12 month time point no significant differences were revealed 
between the groups (Table 4.1.2). First metatarsal shear strength was higher in the 
OVX group than in controls but, unlike torsional strength, the difference was now non 
significant. First metatarsal material stiffness (G) and structural stiffness (GJ) were 
both higher in OVX than in controls but the difference was still not significant. Second 
metatarsal shear strength was found to be higher in controls than in OVX but the 
difference was not significant, nor were the higher material and structural shear moduli 
of controls over OVX significant. When the structural properties (i. e. polar moment of 
inertia (J), from equation 3.1.4) were taken alone and compared between the groups no 
significant differences were observed between the polar moment of inertia of controls 
and that of OVX for I st or 2nd metatarsals. The polar moment of inertia of 2nd 
metatarsals showed a trend towards being higher than that of I st metatarsals in both 
control and OVX animals. Differences in maximum metatarsal diameter at the 
midshaft (D 1) were not significant except that DI of I st metatarsal controls was higher 
than DI of 2nd metatarsal controls (p<0.025). Measurements of maximum cortical 
bone thickness at the rnidshaft (t 1) showed 1 st metatarsal OVX thickness to be 
significantly greater than I st metatarsal controls thickness (p<0.0 1), but no other 
significant differences were observed. It was observed when dissecting out the bones 
that the first metatarsals appeared to be shorter and have a greater diameter than the 
second metatarsals. 
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CalculatedValue IstM/tControls I st M/tarsal OVX 2nd M/t Controls 2nd M/tarsal OVX 
,r (kPa) 516.27±49.03 580.74±22.56 878.29±99.48 815.98±111.65 
G (GPa) 14.89 ± 3.20 20.23 ± 7.16 14.64 ± 2.86 11.56 ± 2.65 
j (M4 x 10-6) 3.18 ± 0.55 3.53 ± 0.38 4.18 ± 0.35 4.04 ± 0.38 
tj (mm) 0.75 ± 0.04 0.85 ± 0.02 0.77 ± 0.05 0.71 ± 0.10 
DI (mm) 4.32 ± 0.10 ** 4.15 ± 0.09 3.96 ± 0.07 3.99 ± 0.10 
GJ (kPa) 42.56 ± 7.11 64.93 ± 15.84 59.99 ± 10.45 45.84 ± 8.63 
Table 4.1.2 Geometrical values (Mean ± SEM) for I st and 2nd metatarsals at the 
12 month timepoint. (** p<0.025 w. r. t. 2nd metatarsal controls; * p<0.01 w. r. t. 1 st metatarsal controls. ) 
2200 1st control torque 
1 st OVX torque u e 
or 
ur 
2nd control torque 
1750 1z.. ** Ist 2nd OVX torque 
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Figure 4.1.1 1 st and 2nd Metatarsal Torsional Strength (Mean ± SEM) 
( ** p<0.025) 
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Figure 4.1.2 1 st and 2nd Metatarsal Torsional Stiffness (Mean SEM) 
* p<0.05 
4.1.2 Four Point Bending - Femora and Humeri 
Values for bending strength fell within a similar range at all timepoints for both control 
and OVX groups (Figure 4.1.3) but the humerus displayed greater bending stiffness 
than the femur at all timepoints for both groups (Figure 4.1.4). The strength of both 
control and OVX femora fell between I month and 6 months; thereafter the strength of 
controls rose more than that of OVX. 
One month after OVX, femoral bending strength in the OVX group fell below that of 
controls (p < 0.01). The strength of bone from controls then fell close to the strength of 
bone from the OVX group at 3 months. At 6 months OVX strength was higher than 
control strength (p < 0.01). By 12 months, the bending strength of femurs from the zn 
OVX group was again lower than that of bones from the control group (p < 0.05). 
No significant difference was seen between the control and OVX femoral stiffnesses 
until 6 months, when the control stiffness fell below the OVX stiffness (p < 0.05). 
However, by 12 months there was again no significant difference between the two Zý 
groups. 
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In the humeri, the stiffness and strength both rose from zero time point in the OVX but 
remained fairly constant in the controls. Values for bending strength and stiffness in 
the control group fell below those in the OVX group at 3 months following OVX (p < 
0.01). The control strength remained below OVX at 6 months (p < 0.01) but by 12 
months post - OVX there were no significant differences in strength or stiffness 
between the groups. 
When the material properties of the bones were calculated from the force - 
displacement curves using equations 3.1.6 to 3.1.8 at the 12 month timepoint (table 
4.1.3) femoral bending strength was found to be significantly higher in the control than 
in the OVX group (p < 0.01). There were no other significant differences between the 
groups. When the structural properties were considered separately, I,, x in the humeri 
and the outside diameters in both the humerus and femur showed trends of being higher 
in the controls than the OVX, but in no cases were these differences significant. 
Femoral thickness was significantly higher in controls than in OVX (p < 0.025) and the z: I 
same effect was seen in the humerus (p < 0.01). 
Calculated Value Femora Controls Femora OVX Humeri Controls Humeri OVX 
a (MPa) 131.7±12.56 *** 95.05 ± 26.90 203.97 ± 53.87 213.97 ± 13.45 
t, (M x 10-3) 1.38 ± 0.10 1.25 ± 0.05 1.05 ± 0.04 *** 0.95 ± 0.01 
DI (M x 10-3) 9.68 ± 0.02 9.74 ± 0.13 6.83 ± 0.35 7.04 ± 0.06 
jxx (M4 XIO-10) 1.44 ± 0.10 1.44 ± 0.09 0.71 ± 0.07 0.62 ± 0.07 
Stiffness (GPa) 29.62 ± 10.60 20.15 ± 3.80 20.41 ± 3.37 30.26 ± 7.57 
Table 4.1.3 Mechanical and geometrical values (Mean ± SEM) for femora and 
humeri at the 12 month timepoint. (** p<0.025 w. r. t. OVX; 
*** p<0.01 w. r. t. OVX) 
97 
z 
900 
800 
700 
600 
500 
400 
300 
200 - 
0 
Femur control strength 
Femur OVX strength 
Humerus control strength 
-e Humerus OVX strength 
,, 
----- 
11 
369 12 
time (months) 
Femoral and Humeral Bending Strength (Mean ± SEM) 
(* P<0.05; *** p<0.01 :F= femora; H= humeri) 
Figure 4.1.3 
z 
C,, 
rID 
1800 Femur control stiffness 
-0 - Femur OVX stiffness 
Humerus control stiffness 
- Humerus OVX stiffness 
1300 
800 
300 ' 
0 
Figure 4.1.4 
-- N- --ý------- 
T 
SF 
369 12 
time (months) 
Femoral and Humeral Bending Stiffness (Mean ± SEM) 
(* p<0.05; *** p<0.01: F= femora; H= humeri) 
98 
4.1.3 Compression - Femora and Humeri 
Humeral cancellous bone was stronger in compression than femoral cancellous bone for 
both groups at every timepoint except for 1 month OVX, when femoral specimens were 
significantly stronger than humeral specimens (Figure 4.1.5). 
Six months following OVX, femoral cancellous bone was significantly stronger in the 
control group than in the OVX group (p < 0.05), but by 12 months this difference was 
no longer significant. Humeral cancellous bone was also stronger in controls than OVX 
6 and 12 months following OVX but these differences were not significant. 
Values for stiffness of specimens of both bones fell into a similar range (Figure 4.1.6). 
Femoral compressive stiffness was higher in controls than in OVX one month after 
surgery (p < 0.025) but by 3 months post-OVX, control specimens were significantly 
less stiff than OVX (p < 0.05). By the six month time point control stiffness was again 
higher than OVX stiffness (p < 0.05) but after 12 months there was no significant 
difference in stiffness between the two groups. There were no significant differences 
between control and OVX stiffness in humeral specimens at any time point. 
99 
I, 
I, 
CD 
35 
30 
25 
20 
15 
10 
5 
0 
0 
Figure 4.1-5 
Femur control stress 
Femur OVX stress 
Humerus control stress 
Humerus OVX stress 
- 
-t-- -, - -- 
369 12 
time (months) 
Femoral and Hurneral Compressive Strength (mean ± SEM) 
* p<0.05: F= femora) 
150 
Femur control modulus 
Femur OVX modulus 
Humerus control modulus 
100 Humerus OVX modulus 
F 
50 
0 
V 
F 
0 
0369 12 
time (months) 
Figure 4.1.6 Femoral and Humeral Compressive Stiffness (Mean SEM) 
(* p<0.05; ** p<0.025: F= femora) 
100 
4.1.4 Density - Cortical and Cancellous bone 
There were no significant differences between control and OVX cortical or cancellous 
bone densities at any time point (Table 4.1.4 and Figure 4.1.7). 
Figure 4.1.8 compares cortical bone density with actual cancellous bone density for 
controls and OVX at each timepoint. In both groups, cortical bone density was higher 
than actual cancellous bone density at every time point. 
Scatter plots of apparent density versus compressive strength (Figure 4.1.9) and 
stiffness (Figure 4.1.10) of femoral and humeral cancellous bone show no correlation 
between apparent density and compressive strength or stiffness. Scatter plots of 1st and 
2nd metatarsal density versus torsional strength (Figure 4.1.11) and stiffness (Figure 
4.1.12) also showed no correlation. Neither was there any correlation between femoral 
and humeral cortical bone density and bending strength or stiffness (Figures 4.1.13 and 
4.1.14). When power calculations were done with respect to the relationships between 
biornechanical variables and density, the value of r was lower in all cases except for 
compressive strength and apparent density of cancellous bone from the humerus, where 
r=0.424; however this was still a very weak correlation. The value of r decreased 
further as the power increased. 
After ashing, the mineral content of the bones was found to be between 55 and 65 per 
cent by weight with no significant difference between control and OVX group means at 
any time point. 
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Figure 4.1.7b Actual, Apparent and Real Femoral Cancellous Bone Densities 
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Figure 4.1.8 Cortical and Actual Hurneral Cancellous Bone Densities 
(Mean ± SEM) 
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4.1.5 Serum Oestradiol and Body Weight 
As seen in figure 4.1.15, variance in terminal serum oestradiol levels was very high. 
There were no significant differences between control and OVX oestradiol levels at any 
timepoint. 
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Figure 4.1.15 Terminal Serum Oestradiol (Mean ± SEM) 
There were no significant differences between mean body weights in control and OVX ZD 
goups at any timepoint (Table 4.1.6). 
Group Time 0 1 mth I mth 3 mth 3 mth 6 mth 6 mth 12 mth 12 mth 
controls OVX controls OVX controls OVX controls OVX 
Weight 3.38±. 27 3.52±. 16 3,79±. 13 4.58±. 15 4.48±. 17 5.04±. 12 4.77±. 23 4.97±. 23 4.74±. 21 
I (kg) I I I I I I II I 
Table 4.1.6 Ten-ninal Body Weights (Mean ± SEM) of Control and OVX Rabbits 
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4.2 Evaluation of Mechanical Properties of Rat Bones 
4.2.1 Three Point Bend Pilot Studies 
Results (mean ± SEM) for each group are shown in table 4.2.1. No significant 
differences were seen between the groups in any parameter except body weight; vehicle 
treated OVX animals were significantly heavier than SHAMs (p<0.01). In the tables 
and figures, asterisks indicate the significance level of the difference between the 
means: *p<0.05, ** p<0.025, *** p<0.01. No asterisks indicate that the 
difference is not statistically significant. 
Group Bending Bending Energy 
Strength (N) Stiffness (Nm') absorbed Body weight(g) 
(jx 10-2 
Shams 
113.71±3.83 31.21±3.39 3.97±0.35 253.7+-+9.47 
OVX, vehicle - 
treated 110.58±2.31 30.03±3.85 3.95±0.29 296.8±2.78 
OVX, 0.03 ýtg 
oestradiol 
114.36±2.33 27.35±2.41 3.92-+0.33 282.1±7.01 
benzoate 
OVX, 0.1 ýLg 
oestradiol 120.56±3.89 35.19±5.33 
3.95±0.58 280.8±3.43 
benzoate 
OVX, 0.3 ýtg 
oestradiol 120.23±5.08 28.18±2.33 4.47+-+0.48 
284.4±6.24 
benzoate II I I 
I able 4.2.1 Tibial 3 point bend values (Mean ± NEM) tor stiam and UVA rats; 
asterisks show significant differences from shams. 
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4.2.2 120 
Oestrogen 
Total and trabecular BMD were shown to be significantly lower in OVX vehicle-treated 
than in sham vehicle-treated animals, while cortical BMD and % porosity trabecular 
bone were significantly higher. The differences between the groups decreased with 
increasing dosage until there was no significant difference between sham and OVX 
cortical BMD with 0.1 ýtg (medium) dosage, and no difference in any of the BMDs or 
the % porosity trabecular bone between sham and OVX groups at 0.3 gg (high) dosage 
(Table 4.2.2). Values recorded at the distal femur and at the proximal tibia, while not 
identical, followed a similar pattern (Figures 4.2.2 - 4.2.5). Figures 4.2.6 - 4.2.9 show 
very clearly the dramatic reduction in trabecular bone at both sites observed in 
untreated animals after OVX. 
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Figure 4.2.5 pQCT distal femur and proximal tibia % porosity trabecular bone 
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Parathvroid Hormone (PTH) 
Significant differences were observed in trabecular BMD between sham vehicle-treated 
and OVX animals with all treatments (Table 4.2.3). No difference was seen in cortical 
BMD between sham vehicle-treated and OVX vehicle-treated animals. Total BNM was 
significantly lower in OVX vehicle-treated and OVX oestrogen treated animals than in 
sham untreated, but not significantly different in those animals treated with PTH or 
PTE and oestrogen combined. OVX animals treated with PTH alone were the only 
group whose % porosity trabecular bone did not differ significantly from that of the 
sham untreated group. Sham animals treated with PTH and with PTH and oestrogen 
combined had significantly higher total BMD and % porosity trabecular bone than 
untreated shams, but trabecular and cortical BMDs remained unchanged. 
No significant differences were observed between corresponding BMD values obtained Zý 
by ashing for any of the groups. 
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Figure 4.2.6 Section through the distal femur of a sham operated rat 
Figure 4.2.7 Section through the distal femur of an OVX rat 
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Figure 4.2.8 Section through the proximal tibia of a sham-operated rat 
A W- 
Figure 4.2.9 Section through the proximal tibia of an OVX rat 
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4.2.3 Femoral Neck Shear StrenLyth 
No significant differences in femoral neck shear strength were observed between any of 
the groups in the oestrogen study (Table 4.2.2). In the PTH study, femoral neck 
strength was significantly lower in baseline OVX than in baseline shams (p<0.05), and 
significantly lower in vehicle-treated (p<0.05) and oes trogen -treated (p<0.01) OVX 
than in vehicle-treated shams. The PTH and PTH and oestrogen combined treated 
groups showed no significant reduction in femoral neck strength compared to untreated 
shams (Table 4.2.3). Shams treated with oestrogen, PTH or both showed no significant 
difference in femoral neck strength from vehicle-treated shams in either study. 
4.2.4 
_Proximal 
Tibia Indentation Strenzh 
In the oestrogen study, OVX tibial indentation strength fell to significantly below that 
of sham-operated animals (p<0.01) and remained significantly lower with low 
(p<0.025) and medium (p<0.01) dose oestrogen treatment. With high dose oestrogen 
there was no significant difference between sham and OVX treated animals (Table 4: 1 
4.2.2). 
In the PTH study, tibial indentation stre ngth was significantly lower in OVX than in 
sham-operated baseline animals (p<0.01). OVX untreated and OVX oestrogen treated 
animals had significantly lower indentation strengths than sham vehicle-treated 
animals. PTH and PTH and oestrogen combined treated OVX animals showed no 
significant differences in tibial indentation strength compared to sham-operated 
controls. PTH and PTH and oestrogen combined treated sham-operated animals had 
significantly higher indentation strengths than untreated shams, but in oestrogen treated 
shams, indentation strength remained the same as in untreated shams (Table 4.2.3). 
4.2.5 Comparison of pOCT with Mechanical Test Values 
Significance of correlation coefficients in this section was calculated using t values at a 
sicynificance level of p<0.05. 4-- 
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A non-significant negative correlation was seen between group mean distal femur total 
BMD and femoral neck shear strength in the oestrogen study, and a significant positive 
correlation (r = 0.870) between group mean total BMD and femoral neck shear strength 
in the PTH study (figure 4.2.10). 
When distal femur total BMD and femoral neck shear strength were compared between 
individual animals the correlation was not significant (figure 4.2.11) (r = 0.539). 
A non-significant positive correlation was seen between group mean proximal tibia 
total BMD and indentation strength in the oestrogen study (r = 0.827) and a significant 
positive correlation between these two parameters in the PTH study (r = 0.921). 
The positive correlations between individual total BMD and indentation strength were 
significant in both studies (oestrogen r=0.785; PTH r=0.874). 
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Figure 4.2.10 Distal Femur pQCT Total BMD versus Shear Strength (Mean) 
(Oestrogen r=0.739, PTH r=0.870) 
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Figure 4.2.11 Distal Femur pQCT Total BNM v. Shear strength - individual animals Oestrogen only (r = 0.539) 
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Figure 4.2.12 Proximal Tibia pQCT Total BMD v. Indent Strength (Mean) 
(Oestrogen r--0.827, PTH r=0.921) 
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Figure 4.2.13 Prox. Tibia pQCT Total BNUD v. Indent Strength - individual animals (0estrogen r=0.785, PTH r=0.874) Z: ý 
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CHAPTER FIVE 
Discussion 
5.1 Rabbits 
Contrary to expectations, OVX did not lead to a reduction in the mechanical 
properties of New Zealand White rabbit bones even after 12 months. 
The first metatarsals showed significantly higher strength and stiffness in torsion than 
the second metatarsals at all timepoints except in the 12 month controls where the 
second metatarsal was significantly stronger than the first (p<0.05). The first Z: ' 
metatarsal is a shorter, wider bone than the second metatarsal and, like its human 
counterpart, the great toe, it is thought to play a larger role in weight bearing than the 
second metatarsal. It has been shown that weight bearing exercise leads to an increase 
in bone density in healthy (Charnay and Tschantz, 1972) and ovarian hormone- 
deficient animals (Westerlind et al., 1995). Between 6 and 12 months an increase in 
torsional strength was seen in both control and OVX lst and 2nd metatarsals, though 
no corresponding increase in torsional stiffness was observed. 
In the femora and humeri, the overall range of strength and stiffness in 4 point Z: 1 
bending did not markedly alter from time zero to 12 months after OVX. Femora from 
the OVX group were significantly weaker in 4 point bending than those from the 
control group one month after OVX but this could be due to post-operative stress. 
This observation emphasises the need to include sham-operated animals as controls in 
these studies, rather than using animals which have not undergone anaesthesia and an Zn 
invasive surgical procedure. At six months, femora and humeri from the OVX group 
were stronger in 4 point bending than those from the control group but 12 months Z: 1 
after OVX this had reversed as the bending strength of femora from the control group 
was significantly higher than those from the OVX group (p<0.05). Zn 
It is not only the size or thickness of bones which is important blomechanically but 
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also their shape. In long bones, the polar moment of inertia (J when the load applied 
is torsional, or I xx when a bending force is applied) is a parameter which measures the 
distribution of the bone material around a central (imaginary) axis running 
longitudinally through the middle of the specimen and was calculated, at the 12 month 
timepoint only, for all the long bones (metatarsals, femora and humeri) in this study. 
It was observed during preparation of the bones that femora and humeri from the 
OVX group seemed to be wider at the midshaft (D 1 and 132) than bones from the 
control group and had thinner walls (t, and t2). On measurement, tI was found to be 
significantly lower in OVX femora and humeri than in controls but although DI was 
larger the difference was not significant. The decrease in wall thickness without an 
increase in whole bone diameter suggests that cortical bone had been resorbed from 
the endosteal surface of humeral and femoral diaphyses. When differences in femoral 
and humeral size and shape were taken into account by calculating the bone bending 
stress and stiffness; no significant differences were found between control and OVX 
femoral stiffness, humeral strength or humeral stiffness. Femora from the OVX group 
were still significantly weaker than those from the control group (p < 0.01). This 
suggests that the decrease demonstrated in whole bone bending strength was due not 
only to geometrical changes in the bone but also to reductions in the quantity of the 
bone material. 
When the shear strength and stiffness of the metatarsal bone at the 12 month 
timepoint were calculated in a similar manner, there were no longer any significant 
differences between control and OVX groups, whereas when the whole bone torque 
and stiffness were calculated the 1 st metatarsal torque was significantly higher in the 
OVX group than that of the controls (p<0.025). This suggests that the observed 
increase in torque in OVX I st metatarsals was due to changes in the bone geometry 
rather than in the bone material. On measurement it was seen that tI of 1 st 
metatarsals from the OVX group was significantly higher than that of controls, but 
there was no difference in D, between controls and OVX. 
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It is possible that errors may have been introduced into the results of the mechanical 
tests from a number of sources: 
In the metatarsals, the calculations done in this study to assess the contribution that 
the geometry of the bones made to their torsional strength and stiffness used a model 
that assumed the bone had a prismatic, el liptical cross-section. Huiskes (1982) stated 
that when the cortical bone material of the human femur was represented by an 
axisymmetric model demonstrating linear elastic, homogeneous and transversely 
isotropic behaviour, excellent agreement between experimental results and theoretical 
predictions was obtained. However, recent research by Leven ston et al. (1994) has 
shown that these methods (i. e. the approximation of bone geometry to a tube with a 
constant cross section) introduce errors of up to 27% in maximum shear stress and up 
to 42% in measurements of shear modulus of the rat femur under torsion, due to the 
anterior bowing of the rat femur. The errors introduced into the measurement of the 
shear stress and modulus of the rabbit metatarsal should be substantially less than in 
the rat femur since the rabbit metatarsal is a straight bone with a reasonably uniform 
cross section . The femora and 
humeri were tested in bending where their curved 
shape would not introduce errors. 
Although every effort was made to keep the bones vertical while the resin was setting 
it is possible that some were not precisely aligned with the testing axis. Any deviation 
would introduce bending moments to the bone, in addition to the required torque, and 
would lead to a lower failure torque. Ideally the strains at the location of interest, 
which is usually the minimum cross section, could be recorded with strain gauges 
during the course of the torsion test. This was not done in this study since the 
metatarsals are small and thus alignment of the strain gauges is difficult. 
Although at six months femoral cancellous bone from OVX animals was significantly 
weaker and less stiff in compression than that from controls, at 12 months there were 
no significant differences in strength or stiffness between control and OVX specimens Z: ý Z-1 
from the femora or the humeri. 
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In cancellous bone testing, errors may have been introduced from various sources. 
Linde and Hvid (1989) have suggested that the results obtained from testing machined 
specimens of cancellous bone do not accurately represent bone properties. These 
authors obtained values for stiffness of cylindrical cancellous bone specimens that 
ranged from 409 ± 53 MPa with no constraint through 488 ± 58 NIPa with 
bone/cement end constraints increasing to 598 ± 68 MPa with a totally surrounding 
steel constraint. They also found that the length to diameter ratio of the machined 
specimen had a significant effect on strength and stiffness values observed - the lower 
the length to diameter ratio, the more significant the test/specimen interface 
mechanics. In 1992, Linde et al. found that both length and cross sectional area of the 
specimens had highly significant effects on the measured mechanical properties. 
Within the length range 2.75-11 mm the modulus was related nearly linearly to the 
specimen length. This was thought to be due to structural disintegrity of the 
specimens near the surface. The modulus was also positively correlated to the cross 
sectional area, probably due to friction induced stress inhomogeneity at the 
plate/specimen interface. However, Tanner et al. (1990) compressed specimens of 
trabecular bone with a constant diameter of 9.5 mm and a range of lengths between 
2.2 and 10.2 mm at 0.017 s-1 and found that only the yield strain was substantially 
affected by the specimen length. Energy absorbed to failure was slightly affected and 
no effect was seen on Young's modulus or strength. Z: ý 
Keaveny et al. (I 993a) suggested that the Poisson's ratio (the amount that the 
specimens will expand or contract widthways when compressed or extended 
unconstrained) for cancellous bone can be large. The higher the Poisson's ratio, the 
greater the effect of friction at the specimen/platen interface on the measured 
mechanical properties. Keaveny et al. (1994a) suggested that the modulus measured 
at the platens may vary from less than 30% to over 175% of the Young's modulus, 
depending on the specimen geometry and the Poisson's ratio of the bone. They also 
found (Keaveny et al., 1994b) that the observed variance in cancellous bone modulus 
and strength was better explained by density when 2: 1 length: diameter cylindrical 
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specimens were used. In the current study, it was found that in some of the animals 
the epiphyseal plate had not yet ossified and this considerably reduced the possible 
specimen length. The length ranged from 3.3 - 7.1 mm for a diameter of 5 nun and 
this may have affected their measured mechanical properties. Another factor to take 
into account when testing any material is whether the testing machine is adequately Z: ' 
stiff and will not add its deflection significantly to the measured specimen deflection 
which is the sum of deflections of the frame and of the specimen alone (Vincent, 
1990). When the machine and testing ng stiffness were measured, it was found that 
errors introduced into cancellous bone stiffness measurements amounted to less than 
3% of the true stiffness values. 
However, errors in mechanical testing methods were probably not the reason that no 
differences were observed in cancellous bone mechanical properties between control 
and OVX groups as they probably would have occurred equally in both groups. Also, 
no differences were observed between apparent density of cancellous bone in control 
and OVX groups even when power calculations were done, which indicates that OVX 
did not lead to a loss of cancellous bone. Additionally, the ash weight was the same in 
control and OVX groups. However, while density is a useful measure of the amount 
of bone present within a given volume it is not a measure of distribution; measures of 
trabecular connectivity relate more to biornechanical competence than do measures of 
density (Mosekilde et al., 1987). 
The animals were housed in cages, rather than pens, which did not give them room to 
run around. This may have led to unloading of the femora, and this seems probable 
since bending strength of control and OVX femora fell between I and 6 months. 
Unloading has been shown to lead to increased osteopaenia in OVX animals 
(Westerlind et al., 1995) and so the difference in strength observed between control 
and OVX femora may have been real but there is also a probability of 1% that it could 
have arisen by chance. This seems a reasonable explanation in this study because 
there were no significant differences observed between control and OVX cancellous 
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bone compressive strength or stiffness at any timepoint. Although Squillante and 
Williams (1993) believed that changes in cortical bone contributed the most to 
osteopaenic fracture, most other authors agree that changes in bone due to 
osteoporosis are seen first in cancellous bone (Ruegsegger et al., 198 1; Hodgkinson 
and Currey, 1990a; Lindsay and Cosman, 1992). 
Because looking at disorders of bone metabolism involves working with living 
creatures, true "before and after OVV values for the strength and stiffness of bone 
cannot be obtained. Instead, it is necessary to compare the strength and stiffness of 
bone from control animals with the strength and stiffness of bone from different 
animals which have been ovariectomised, after a set period of time. The amount of 
variation which would be expected between animals falls in the range 10-15%. 
Therefore in order to be statistically significant, any differences which do arise in 
bone strength and stiffness due to OVX must be 10- 15% larger than they would have 
to be if "before and after OVV values were compared in the same animal. This 
means that there may be small differences in bone strength and stiffness induced by 
OVX in the NZW rabbit but these may be masked by noise due to normal biological 
variation. This is why it is important, when choosing an animal model for post- 
menopausal osteoporosis, to choose one which responds to OVX with dramatic 
changes in bone metabolism in a reasonable timescale so that these changes can then 
be seen between groups of OVX and control animals. 
It appears that OVX had no effect on the skeleton of the NZW rabbit even 12 months 
after surgery. Body weight has been observed to increase in rats following OVX, but 
there were no differences between body weight of control and OVX rabbits in this 
study. Post-mortem observations on the animals confirmed that OVX had been 
successful (i. e. had removed all ovarian tissue) in all but one of the animals. However 
when oestradiol levels were measured in serum taken from the animals just prior to 
sacrifice, it was seen that circulating oestradiol levels were very low in both control 
and OVX animals and that there were no differences in serum oestradiol levels 
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between the groups at any timepoint. In human pre-menopausal women oestradiol 
levels vary from between 100 and 700 pg ml-1 depending on the stage in the 
menstrual cycle (Guyton, 1984). The oestradiol levels of the animals in this study 
were seen to vary widely within each group, from below 3.7 to 48.9 pg ml-1, and did 
not appear to be affected by OVX. Low levels of circulating oestradiol have also 
been observed in rabbits by other workers (Orstead et al., 1988) and suggest that the 
rabbit is not markedly dependent on ovarian hormones to protect the skeleton. 
Rabbits enter oestrous only upon mating and so the virgin NZW rabbits used in this 
study had presumably never had an oestrous cycle. The long oestrous cycle of dogs 
has been suggested to have an effect in making bone less sensitive to oestrogen loss 
and provoking a need for a long observation period following OVX before any effects 
are seen (Yamaura et al., 1993). The absence of an oestrous cycle may have a similar 
effect on the skeleton of the NZW rabbit. It is also possible that other factors, such as 
bone cell mitogens which have been demonstrated originating from the uterus in OVX 
mice in response to oestrogen (Bain et al., 1992), may have a role in the regulation of 
bone turnover in NZW rabbits. Furthermore, the NZW rabbit has abundant adipose 
tissue and it is possible that fat-derived oestrone may protect the skeleton from the 
effects of ovariectomy. 
Thus, rabbits do not appear to be a suitable species to be used as a model for human 
post-menopausal osteoporosis. 
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5.2 Rats 
The OVX rat has been used as a model for human post-menopausal osteoporosis 
because it responds to loss of ovarian hormones by an increase in body weight and by 
a decrease in bone mineral density (BMD) (Wronski et al., 1989; Omi et al., 1992) as 
in humans. However, the rat skeleton is unlike the human skeleton in that it is 
continually growing. Kalu (1991) stressed the importance of selecting skeletally 
mature rats i. e. rats in which the period of rapid skeletal growth is over. He suggested 
two rat models - mature and aged. The aged rat model resembles human post- 
menopausal osteoporosis more closely than the mature rat model, but is much more 
expensive and the effects of OVX on their bones are not seen for a long time. The 
mature (approximately 3 months old, sexually mature) rat model is cheaper and more 
readily available. The effects of OVX on the skeleton can be detected after 
approximately one month and the nature of the bone loss is largely similar to that of 
the aged rat model. The rat skeleton does not undergo Haversian remodelling at all 
sites and this could be a major problem when it is used as an animal model, since the 
aetiology of post menopausal osteoporosis may lie in a remodelling defect. 
However, remodelling of cancellous bone has been demonstrated at some sites (Baron 
et al., 1984) and remodelling of cortical bone has been observed in extreme 
conditions such as low dietary calcium stress (Kalu et al., 1989), making it probable 
that the rat skeleton does possess the ability to undergo remodelling and that a similar 
remodelling defect to that present in humans with post-menopausal osteoporosis may 
also be present in the OVX rat model. 
In the pilot study, the increase in body weight observed in OVX untreated animals 
indicated that OVX was successful, i. e. resulted in loss of ovarian hormones which 
altered the skeletal metabolism of the animals. The fact that parallel significant 
reductions in femoral bending strength and stiffness were not observed was probably Z: ) 
due to the short time scale of the experiment. As discussed in section 2.6.3, it can 
ta-ke over 18 months following OVX for a reduction in the strength of cortical bone to 
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be seen (Danielsen et al., 1993). At this point it was decided to concentrate on areas 
consisting wholly or largely of cancellous bone, namely the proximal tibia and 
femoral neck. Wronski et al. (1989b) observed a significant reduction in trabecular 
bone volume (TBV) 1 month after OVX in mature rats. A decrease in the strength of 
the femoral neck was observed 8 weeks after OVX (Kharode et al., 1993; Zhiqi et al., 
1993), but Toolan et al. (1992) found no reduction in femoral neck strength 10 
months after OVX. 
In the PTH study, OVX animals were left untreated for 7 weeks, then treated for 5 
weeks with PTH (an anabolic therapy), PTH + oestrogen (a combined therapy) or 
oestrogen on its own (for comparison of an antiresorptive therapy with an anabolic 
therapy). Those that were "treated" with Arachis oil (the drug carrier, as a control) 
were effectively left in an oestrogen-deficient state for 12 weeks. In the oestrogen 
study OVX animals in the vehicle-treated group were left in an oestrogen deficient 
state for 6 weeks. From the literature it was anticipated that it would be possible to 
detect a decrease in femoral trabecular BMD in the vehicle-treated OVX group in the 
PTH study but possibly not in the oestrogen study, since differences between sham 
and OVX groups tended to be greater 12 weeks post-OVX than 6 weeks post-OVX. 
In the oestrogen study, total and trabecular BMD were significantly decreased at both z: 1 
sites in OVX untreated animals (cortical BMD and % porosity trabecular bone 
correspondingly increased) and in the PTH study total and trabecular BMD at the 
distal femur were also significantly decreased in OVX untreated animals and the % 
porosity trabecular bone increased. Thus, OVX had had a detrimental effect on 
cancellous bone density after just 6 weeks. Low dose oestrogen therapy did not 
restore total, trabecular or cortical BMD, or % porosity trabecular bone, to sham 
values in OVX animals. Medium dose oestrogen therapy restored cortical BMD to 
sham values, but total and trabecular BMD, and % porosity trabecular bone, remained 
significantly below sham levels. With high dose oestrogen therapy, total, trabecular 
and cortical BMD returned to normal, as did % porosity trabecular bone, which 
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suggests that this dose was sufficient to prevent post-OVX bone loss. In the PTH 
study, oestrogen therapy did not return values for total or trabecular BMD or % 
porosity trabecular bone in OVX untreated animals to those of sham-operated 
animals. This result was expected since all the animals had been left untreated for 7 
weeks before treatment began, and oestrogen is an anti-resorptive agent. An anabolic 
agent was needed to restore BMD. PTH alone restored values for total BMD and % 
porosity trabecular bone in OVX animals to the same as those in sham-operated 
animals, but failed to restore trabecular BMD. The increase in total BMD was due to 
an increase in cortical BMD although this was not significantly higher in PTH treated 
OVX animals than in vehicle treated OVX animals. As cortical BMD was higher in 
OVX untreated animals than in sham vehicle treated animals it appears that the loss of 
ovarian hormones, rather than the treatment with PTH, was the factor that caused the 
increase in cortical BMD. A similar increase was seen in the vehicle treated and low- 
dose OVX groups in the oestrogen study. Treatment with PTH plus oestrogen failed 
to restore trabecular BMD or % porosity trabecular bone to sham values, but did 
restore total BN4D; this may be because cortical BMD was increased the most in this 
group. 
The use of pQCT in this study was a pilot study of the potential of the technique as a 
method for detecting reductions in bone strength so little characterisation was done 
but if the method were to be used in future studies on rat bones it would require 
additional characterisation. For example, the threshold value for cortical BMD may 
need to be adjusted since BMD values could be prone to partial volume errors. 
Histomorphometric analysis should be carried out on trabecular bone since lost 
trabecular bone is often replaced by fat and this can affect the detected trabecular 
BNID (Breen et al., 1996). 
No significant differences were seen in BMD between any of the groups when the 
bones were ashed. Ashing cannot pick up differences in cortical and cancellous BMD 
and this is one of the advantages pQCT has over ashing. Zý 
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In the PTH study, femoral neck shear strength was significantly lower in baseline z: 1 
OVX than in baseline shams and in vehicle treated and oestrogen treated OVX than in 
shams. However, in the oestroggen study no significant differences were observed in 
femoral neck shear strength; in fact, in the vehicle treated OVX group femoral neck 
strength shows a trend towards being higher than in shams. This could be because the 
femoral neck consists of both cortical and cancellous bone and it has already been 
observed that cortical BMD was increased in the distal femur in OVX vehicle treated 
and low dose oestrogen- treated groups. This increase in cortical BMD could be 
sufficient to cancel out the negative effect of the decrease in trabecular BMD 
observed in these groups on shear strength. On the other hand, differences in femoral 
neck shear strength may have been present but the test was unable to pick them up 
due to high variance introduced by errors in the test set-up. This is suggested by the 
fact that some reductions in strength were observed in the PTH study in the groups in z: 1 
which these reductions would be expected to occur i. e. baseline OVX were 
significantly less strong than baseline shams, and vehicle-treated shams were ZD tý 
significantly stronger than vehicle-treated OVX and oestradiol-treated OVX. In the ZD Z: ý 
PTH study, femoral neck shear strength was restored to vehicle treated sham levels in 
OVX animals treated with PTH alone and with PTH and oestrogen combined, despite 
no concomitant increase in trabecular BNID. 
It was important while performing the tests to set up the bones in identical positions in 
'ble due to slight differences in the shapes of the testing jitg. This was not always possi izn 
the bones. If the jig were modified to adapt to variations in bone geometry the test tý 
could possibly be made more sensitive. 
If the failure of OVX to reduce femoral neck shear strength in the oestrogen study was Z: ý 
due to an increase in cortical bone strength, proximal tibial indentation strength z: 1 
would have been expected to fall significantly after OVX since only the cancellous 
bone was being tested. This predicted effect was shown to occur, since specimens 
from OVX vehi cle- treated, low and medium dose oestrogen treated groups were Z: ) 
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significantly weaker than sham-operated specimens, and high-dose oestradiol-treated 
were not significantly lower than shams. All the expected differences were also 
observed in the PTH study, with baseline OVX strength significantly lower than that 
of baseline shams, strength of vehicle-treated and oestrogen treated OVX significantly 
lower than that of vehicle-treated shams and strength of PTH and PTH-plus-oestrogen 
treated shams significantly higher than that of vehicle-treated shams. PTH therapy 
and PTH plus oestrogen therapy restored proximal tibial indentation strength to the 
level of vehicle treated shams, despite failure to produce a corresponding increase in 
trabecular BMD. This suggests that the differences seen in this test reflect real 
differences in cancellous bone strength. This is probably because this test was simple 
to set up and reproducible, with the same distance being travelled by the indenting 
needle each time. However, the greater differences seen between groups with this test 
than with the femoral neck shear test may not be all due to the superiority of the tibial 
indentation test over the femoral neck shear test, since it has been suggested that the 
cancellous bone of the proximal tibial metaphysis is more metabolically active than 
the cancellous bone of the femoral neck, the tibial plateau containing red marrow and 
the femoral neck yellow marrow (Steer et al., 1994). 
The significant positive correlations seen between pQCT proximal tibial total BMD 
and indentation strength using individual values in both studies and the group mean in 
the PTH study, indicate that total BMD could be a useful predictor of cancellous bone 
strength. Femoral neck shear strength was also significantly correlated with distal 
femur total BMD in the PTH study but not in the oestrogen study. This is probably 
due to problems with the test and does not detract from the potential value of pQCT in 
predicting cancellous bone strength. The correlations between strength and total 
BMD were non-significant in the distal femur when individual animals rather than 
group means were compared, contrary to expectations; however at the proximal tibia 
the correlation was highly significant. One of the major advantages of pQCT is that, 
being non-invasive, the changes in BMD due to OVX and treatment can be studied 
longitudinally within an individual animal. If these changes were proven to be z: 1 
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reliable predictors of changes in bone strength the number of animals needed within 
each group to get a statistically significant result could be reduced from 10 to 3-a 
reduction of 70%. This would reduce costs due to animal maintenance and reduce 
costs due to mechanical testing, in addition to the ethical benefits of reducing the 
numbers of animals used experimentally. 
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CHAPTER SIX 
Conclusions 
Rabbits 
1. The New Zealand White rabbit's apparent lack of dependence on oestrogen 
and the long duration needed to detect bone loss mean that as a model for human post- 
menopausal osteoporosis this species has no advantage over other species eg. sheep 
which are oestrogen dependent and provide large bone samples for testing (Homby et 
al., 1994) and is not suitable to be used as such. 
2. The strength, stiffness and density of cancellous bone from the humeral head Z: ý 
and femoral intercondylar areas were not significantly altered by OVX, even after 12 
months. 
3. OVX in the New Zealand White rabbit brought about small changes in the 
bending strength of the femora but only after 12 months. 
4. OVX in the New Zealand White rabbit seemed to have a greater effect on 
cortical bone than on cancellous bone. 
5. OVX did not affect oestradiol levels, which remained low in each group. 
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Rats 
1. OVX led to a significant decrease in cancellous bone density and a significant 
increase in cortical bone density, as measured by peripheral quantitative computer 
tomography, 6 weeks following OVX. 
2. OVX led to a significant decrease in the indentation strength of cancellous Zý 
bone from the proximal tibia. 
3. Total BN/ID was strongly correlated with indentation strength in the proximal 
tibia (r = 0.92 in the PTH study). 
4. The highest dose of oestrogen therapy (0.3 ýLg per rat) prevented post-OVX 
cancellous bone loss and cortical bone gain. Z: ý 
5. The highest dose of oestrogen therapy (0.3 ýig per rat) maintained proximal 
tibial indentation strength when given to OVX animals. 
6. PTTi treatment did not restore cancellous bone density to sham levels when 
given to OVX animals after a treatment-free interval. 
7. PTH and PTH plus oestrogen therapy restored both femoral neck shear 
strength and proximal tibial indentation strength to untreated sham levels when given 
to OVX animals after a treatment-free interval. 
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CHAPTERSEVEN 
Future Work 
It would be of interest to investigate the effects of oestrogen treatment on normal and Z: ý 
OVX rabbits to determine whether bone mass and mechanical properties can be 
increased by oestrogen in non-OVX rabbits. The effects of OVX on a thinner breed 
of rabbit might be of further interest to determine whether adipose tissue plays a 
significant role in protection of the skeleton following OVX. 
Further investigation of the timescale of changes in bone turnover in the OVX rat 
would be appropriate, possibly by marking the bone with fluorescent agents including 
tetracycline and xylenol orange. Bone resorption should be assessed at the same time 
by measurement of the hydroxyproline / creatinine ratio. Further investigation of the 
correlation between total BNM as measured by pQCT and cancellous bone strength in 
animal models of post-menopausal osteoporosis would also be a useful study. Further 
work using the cancellous bone indentation test developed here for rats (or suitable 
adaptations) would be of interest to determine whether the changes in strength, 
produced by OVX, at the rat proximal tibia are produced in other areas of cancellous 
bone e. g. the distal femur. The femoral neck jig used in this study could be further 
refined to achieve a more reproducible test with a lower coefficient of variance. 
Lastly, it would be of interest to investigate measures of structure (connectivity etc) in 
the cancellous bone of the femoral neck and proximal tibia to determine why PTH and 
PTH plus oestrogen therapy restored strength without increasing density of cancellous 
bone in these areas when given to OVX animals after a treatment-free interval. z: I 
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GLOSSARY 
ADIPOSETISSUE Tissue containing cells which store fat (better known as just 
fat). 
APPOSITION The state of two structures being in close contact. 
ARACHIS OIL Also known as groundnut or peanut oil, this is used as a carrier, 
or vehicle, for many injectable drugs. 
BIPHASIC MATERIAL A phase is a homogeneous portion of a system that has 
uniform physical and chemical characteristics. The two phases in a biphasic material 
interact in such a way that the property combination is better than the properties of 
either of the individual phases. 
BRUSH BORDER A dense covering of microvilli on the free surface of some 
cells, including osteoclasts. 
COMPOSITE MATERIAL A material that consists of more than one 
material type e. g. fibreglass reinforced polymers. 
ELASTIC DEFORMATION Deformation that is non-permanent i. e. is totally 
removed on release of the applied stress. 
ISOTROPY Having identical values of a property in all directions. 
LYSOSOME A particle in the cytoplasm of cells that contains enzymes 
responsible for breaking down substances in the cell and is bounded by a single 
membrane. 
OSTEOLYSIS The breakdown of bone, by enzymes secreted from lysosomes 
OVARIECTOMY The surgical removal of all ovarian tissue. 
PLASTIC DEFORMATION Deformation that is permanent or non - 
recoverable after release of the applied load. 
PROHORMONE An inactive precursor from which a hormone is derived. 
SHAMS Sham-operated animals which act as controls for animals which have 
undergone an invasive surgical procedure. Shams are given the same anaesthetic and a Z: I Z: I 
similar skin incision as the non-controls, and they recover from the "operation" in the 
same conditions as the animals which have been operated on. 
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STRAIN The change in the length of a material due to an applied force, 
expressed as a fraction of the initial length. No units; sometimes expressed as a 
percentage. 
STRESS Force per unit area, measured in Pascals (Pa). 
ULTIMATE STRESS The maximum stress a material reaches. 
VEHICLE The carrier for a drug. The quantity of drug needed is often very small 
and inert carriers are necessary to make the drug easier to handle. The vehicle used 
for the injectable drugs in this study is arachis oil. 
YOUNG'S MODULUS The ratio of stress to strain when deformation is totally 
elastic; it is a measure of the stiffness of a material. 
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